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Silicosis and coalworkers' pneumoconiosis are lung diseases associated with occupational
exposure to silica and coalmine dust, respectively. The definitive lesion in both diseases is
lung fibrosis but emphysema accompanies coalworkers' pneumoconiosis and is also reported
to be present in silicosis, although its relation to the fibrotic lesion is still controversial. A
characteristic feature of pneumoconiosis is the accumulation of increased numbers of
inflammatory leukocytes in the alveolar region of the lung and these cells have been
implicated in the pathogenesis of the disease. Neutral proteinases, released by
inflammatory leukocytes, have been shown previously to damage cellular and connective
tissue components of the alveolar septa and may thus contribute to the tissue derangements
of fibrosis and emphysema. A role for leukocyte neutral proteinases in the aetiology of the
pneumoconioses emanates from studies demonstrating both increased levels of elastase in
pneumoconiotic bronchoalveolar lavage fluid and increased elastase secretion by
bronchoalveolar leukocytes from pneumoconiotic patients. However,there have been few
studies to specifically investigate the proteolytic activity of the bronchoalveolar
leukocytes in pneumoconiosis. The aim of the present study was, therefore, to assess the
bronchoalveolar leukocyte response and proteolytic activity of the leukocytes in a rat
model of pneumoconiosis.
An assay, based on the breakdown of [^^I]fibronectin, that would measure the overall
proteolytic activity of the bronchoalveolar leukocytes and indicate their potential to
damage the septal connective tissue, was developed and validated. Increased proteolytic
activity was found in the inflammatory bronchoalveolar leukocyte populations and so the
relative role of macrophages and neutrophils was assessed by separation into distinct
populations. Neutrophils had the greatest ability to degrade connective tissue molecules,
being at least 5-fold more active than resident macrophages but inflammatory
macrophages also had increased proteolytic activity that was 3-fold more than the
control macrophages.
The important features governing the inflammogenicity of particles were addressed by
measuring the inflammation-generating properties of a variety of fibrogenic and non-
fibrogenic particles in rats exposed by intratracheal instillation or inhalation. To assess
the extent of the alveolitis generated by such treatment, the number and type of leukocytes
recruited to the alveolar region was measured by bronchoalveolar lavage and the
proteolytic activity of the leukocytes was assessed. Multiplying the total number of
leukocytes recruited by the proteolytic activity per cell gave an indication of the potential
proteinase burden in the alveolar region. In the acute phase following intratracheal
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exposure, the fibrogenic dust quartz elicited levels of leukocyte recruitment that were
similar to that evoked by non-fibrogenic particles and the proteolytic activity of the
leukocytes was also similar. However, only quartz had the ability to maintain a sustained
alveolitis in which the proteolytic activity of the bronchoalveolar leukocytes remained
elevated. This indicated that the duration, rather than the initial magnitude of the
inflammation might be an important factor in determining the pathogenic potential of
dusts. This suggestion was supported by the finding that in rats exposed to coalmine dust by
inhalation, the inflammatory response gradually increased with duration of dust exposure
but it did not exceed the acute response to intratracheally injected particles. The
inflammation did, however, persist long after the cessation of dusting and so the difference
between fibrogenic and non-fibrogenic particles appears to be related to the duration of the
inflammatory response which they can evoke in the lung. The sustained alveolitis with
fibrogenic particles was not related to lack of clearance of dust from the lung. Both quartz
and coalmine dust elicited a sustained alveolitis, but titanium dioxide, which is no more
readily cleared than silica or coalmine dust, failed to sustain the inflammation.
Altering the surface of quartz particles by coating them with aluminium lactate reduced
their ability to recruit inflammatory leukocytes but did not alter the proteolytic activity
of the leukocytes. The tissue response to the coated quartz particles was also less than
that elicited by native quartz with fewer and less-severe lesions.
The foregoing serve to substantiate the role of inflammatory leukocytes in the
pathogenesis of the pneumoconiotic disease process. Only when there is a sustained
alveolitis with an overall increased proteinase burden, does pathological change occur in
the lung. Reducing the magnitude and/or the duration of the alveolitis markedly
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1.1. Aims of the thesis
Silicosis and coalworkers' pneumoconiosis are lung diseases associated with occupational
exposure to silica and coalmine dust respectively. The definitive lesion in each case is lung
fibrosis but this may also be accompanied by emphysema. Chronic alveolitis is a
characteristic feature of both diseases and the inflammatory leukocytes are deemed to be
central to the pathogenic process. Degradation of lung tissue by leukocyte proteinases has
been implicated in the development of lung pathology in other chronic inflammatory
diseases of the lung such as adult respiratory distress syndrome (ARDS) and idiopathic
pulmonary fibrosis (IPF). By inference, the same may also be true of coalworkers'
pneumoconiosis and silicosis but little previous work has specifically addressed this
question. The primary aim of the work described in this thesis was, therefore, to
investigate the role of connective tissue proteolysis by inflammatory leukocytes in the
pathogenesis of coalworkers' pneumoconiosis, silicosis and emphysema. The specific aims
of the thesis are described in the following sections.
1.1.1. Development of the proteolysis assay
Much of the previous work on leukocyte proteinases has investigated the proteolytic
activity of leukocytes by measuring their secretion or content of a specific proteinase. A
primary objective of this thesis was to develop an assay of connective tissue proteolysis
which would measure, the entire activity of viable bronchoalveolar leukocytes in
degrading connective tissue molecules in vitro.
1.1.2. Assessment of the relative proteolytic activity of inflammatory
macrophages and neutrophils
The leukocytes of a non-immune alveolitis are comprised mainly of macrophages and
neutrophils. Both types of leukocyte secrete proteolytic enzymes and could therefore
contribute to tissue damage in chronic alveolitis. Knowing the potential contribution that
each leukocyte type could make to the overall proteinase burden in the lung might be of use
in developing therapeutic intervention in the disease process. A further aim of this thesis
was therefore to obtain inflammatory bronchoalveolar macrophages and neutrophils and
to assess the relative proteolytic activity of each population.
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1.13. Investigation of the role of persistent inflammation in causing tissue
injury
Exposure to harmful mineral dust particles is frequently associated with pathological
change in the lung but most microbial infections resolve without pathological change. The
difference between these two types of inflammogen in terms of their ability to cause long-
term damage in the lung may be related to the degradeability of the microbes. A further
aim of the thesis was therefore a) to investigate differences between microbial and
mineral dust challenge in the lung by measuring the persistence of alveolitis following
deposition of degradeable and non-degradeable particles by intratracheal injection, and b)
to assess the ability of bronchoalveolar leukocytes from the lungs of rats injected with
microbes or mineral dust particles to degrade connective tissue molecules using the
proteolysis assay described in 1.1.1. above.
1.1.4. Assessment of the alveolitis in rats exposed to coalmine dust by inhalation
Intratracheal injection is a valuable tool in answering basic questions regarding the
pathogenesis of lung disease but it is not entirely representative of the real life situation
when dust is inhaled. Deposition of airborne dust in the alveolar region is related to
aerodynamic properties of the dust in the complex branching airway system of the lungs.
An additional aim of the thesis was therefore to assess the development of alveolitis in
rat lungs exposed to coalmine dust by inhalation and to assess the proteolytic activity of
the bronchoalveolar leukocytes as above.
1.1.5. Investigation of the biological reactivity of quartz in relation to the surface
of the quartz particles
Some forms of silica, especially quartz, can be highly fibrogenic and the pathogenicity of
some coalmine dusts has been related to their quartz content. The harmful effects of quartz
are thought to be associated with silanol groups on the particle surface which may react
with cells by acting as hydrogen donors and thus cause membrane damage. The final aim of
the thesis was to investigate the importance of the quartz surface to its biological
reactivity by measuring the ability of surface-modified quartz to elicit and sustain an
alveolitis.
1.2. Origin and functions of leukocytes
Leukocytes, or white blood cells, are a major component of the host defence system of the
body (Klempner, Styrt and Ho, 1989). They originate in the bone marrow and, in subsequent
divisions, differentiate to form a variety of lineages with different functional capacities.
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They then enter the bloodstream where they remain for varying periods of time before
passing into the tissues, prior to further differentiation. Pluripotent stem cells give rise to
two distinct lineages:- (1) lymphoid - which differentiates to form the T- and B
lymphocytes and (2) myeloid- which gives rise to the monocyte/macrophages, the
polymorphonuclear leukocytes (neutrophils, eosinophils and basophils) and also to
platelets and mast cells (Nauseef, 1989). Each of these cell types has a specific role to
play in host defence.
Monocytes form a pool of cells (2-20% of circulating leukocytes) in the bloodstream, which
migrate into the tissues to give rise to the more-differentiated tissue macrophages.
Macrophages and monocytes share similar functional characteristics such as phagocytosis
and killing of bacteria, antigen presentation to T lymphocytes and secretion of regulatory
molecules (cytokines/monokines) (Vaes, 1985; Ho, 1989). Via the latter two functions,
macrophages can orchestrate the responses of other leukocytes and are thus pivotal to the
host defence system (Vaes, 1985).
Amongst the polymorphonuclear leukocytes, neutrophils are the most common, forming 40-
75% of circulating leukocytes in the bloodstream; eosinophils and basophils represent less
than 0.2%. The primary function of the neutrophil is bacterial killing and this is reflected
in the rapid recruitment of large numbers of neutrophils to sites of infection/inflammation
(Baggiolini and Dewald, 1985).
Lymphocytes form 20-50% of the circulating leukocytes, and are also found in lymphoid
organs in the tissues. Both T- and B lymphocytes are involved in specific recognition of
antigen and the response to it. T cells responding to antigen challenge undergo clonal
expansion and then perform several different functions including "help" to other
lymphocyte responses (Th cells), cell-mediated killing (Tc cells) and production of
regulatory lymphokines (Tdth cells); gamma-interferon is a particularly potent mediator
secreted by Tdth lymphocytes and is a very effective activator of macrophages and other
cells. B cells secrete antibodies, specific globular proteins which combine with antigen;
this interaction neutralises microbes, enhances phagocytosis, activates complement and
facilitates antibody-dependent cellular cytotoxicity.
1.3. The host defence systems of the body
The responses of the host defence system can be divided into two categories - innate and
adaptive (Roitt et al, 1985). The body is continually exposed to a low level of microbial
challenge, particularly at epithelial surfaces such as those lining the respiratory tract,
the digestive tract and the skin. This low-level threat is dealt with by the innate immune
19
system which comprises:- (a) soluble factors such as lysosyme and complement (activated
directly by microbes via the alternative pathway) which act to kill or opsonise the
microbes; (b) cellular elements- these are the NK cells which kill virally infected cells,
and macrophages and neutrophils which phagocytose and then kill microbes. Microbial
killing by macrophages and neutrophils can take place both intra- and extracellularly by
release of proteolytic enzymes and reactive oxygen species into the extracellular
environment.
Low level bacterial challenge can be dealt with by the tissue macrophages and NK cells
but where the microbial challenge increases to levels that overload these first line
defences (infection), the mechanisms of innate immunity are enhanced and inflammation
results. At the site of inflammation, increased capillary permeability permits diffusion of
important defensive plasma components such as immunoglobulins to the site of tissue injury
(Jones et al, 1982). The acute phase proteins, induced in the liver by increased circulating
interleukin-1 (IL-1, released by leukocytes at the focus of inflammation) enhance
complement activation to generate the anaphalatoxin, C5a. C5a is also generated
following activation of complement by the alternative pathway through interaction with
bacterial surfaces. The generation of a C5a gradient at the site of inflammation then causes
blood leukocytes (first polymorphonuclear leukocytes and then monocytes) to migrate from
the blood capillaries up the chemotactic gradient, and into the inflamed tissue. Other
mechanisms involved in leukocyte recruitment are discussed in further detail in 1.5.3.
Neutrophils constitutively contain more proteolytic enzymes than macrophages and the
initial influx of neutrophils to the inflammatory site generally facilitates rapid clearance
of the invading organism. In this respect neutrophils are generally considered to be the
classical cell of the acute inflammatory response. Monocytes are recruited later than
neutrophils and may therefore be of greater importance to the regenerative phase of the
inflammatory response (Vaes, 1985; Fotev et al, 1987).
The adaptive immune response involves macrophages and T- and B lymphocytes
principally (Roitt et al,1988). During initial exposure to immunogenic material, limited
B- and T cell responses are produced (see 1.2). In addition, a class of lymphocytes called
memory cells are generated. On subsequent exposure to the antigen, this enables a quicker
and larger response to occur through clonal expansion of the memory cells. Macrophages
are central to the adaptive immune response through their ability to digest phagocytosed
microbes and then present the bacterial antigen, to the immune system at their cell surface.
Adaptive immune responses go on at a constant low level in the body without inflammation
developing but when the amount of immunogenic material in the body becomes increased,
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high levels of circulating antibody and/or effector T cells are produced and an
inflammatory response develops as above.
The two systems of innate and adaptive immunity are thus closely interlinked at all levels
and involve interactions between myeloid and lymphoid cells. The outcome of this cellular
cooperation is the rapid elimination of microbes and protection against host tissue damage.
Leukocytes are found in all tissues of the body in anticipation of a microbial challenge.
This is particularly true of the lung where exposure to inhaled material poses a constant
potential threat of infection. This thesis is concerned particularly with macrophages and
neutrophils obtained by bronchoalveolar lavage and so the specific role of these cells in
lung defence and disease will be discussed in further detail in succeeding sections.
1.4. Host defence in normal lungs
1.4.1. Physical parameters
The air we breathe contains many particles but not all of these gain access to the delicate
tissues of the alveolar region. There are several defence mechanisms in the upper
respiratory tract which ensure that the majority of inhaled particles are cleared before
they reach the deep lung (Raabe, 1984):- (a) nasal hairs- these act as filters to trap large
particles; (b) the mucociliary escalator- the majority of particles which penetrate into the
upper respiratory tract deposit on the walls of the bronchi and are trapped in the rafts of
mucus produced by other cells, which line the whole of this area. Ciliated cells on the
surface of the bronchi then waft the mucus, with trapped particles, up to the throat where
it is eliminated from the lung by swallowing or spitting. The deposition process is aided by
the branching structure of the bronchi. This forms a tortuous route for the airflow and so a
large proportion of the particles impact at bronchial bifurcations; (c) deposition of inhaled
material in the lung is also highly dependent on particle size - particles of large
aerodynamic dynameter (>10 microns) deposit in the airways very quickly by impaction or
sedimentation and are then removed on the mucociliary escalator, whilst some particles
(<0.5 microns) tend to remain airborne and are carried out of the lungs in the expired air.
Particles 1-5 microns in diameter penetrate to the alveolar region and have a high
likelihood of depositing there (the alveolar deposition fraction).
1.4.2. Cellular aspects of host defense in normal lungs
The mucociliary escalator does not extend beyond the respiratory bronchioles and so for
those particles which do penetrate to the alveolar region and deposit in the alveoli, some
other clearance processes must operate. The resident macrophages are the primary line of
21
defence against inhaled particulate material in the alveolar region (Green et al, 1977) and
are central to all host defence functions in that area. Most of the particles which deposit in
the deep lung are phagocytosed by macrophages and then broken down within lysosomes or
they may be transported intracellularly to the mucociliary escalator or to the lymph nodes
(Lehnert et al, 1988).
The major means of removing microbial particles from the lung is killing and digestion by
macrophages and neutrophils and this is mediated largely by two mechanisms:-
1 oxygen-dependent processes - reactive oxygen species such as superoxide anion,
hydrogen peroxide and hypohalide are generated from molecular oxygen by
oxidases. These oxidants are highly effective bactericidal agents (Klebanoff and
Hamon, 1975; Babior, 1978). Killing via oxidative interactions with the bacterial
membrane takes place in both the intra- and extracellular environments (Nathan et
al, 1980);
2 oxygen-independent processes - shortly after phagocytosis of microbes the
phagosome fuses with an enzyme-containing lysosome and the pH of the
phagolysosome then falls rapidly to around pH 4.0. The low pH and the presence of
cationic proteins is thought to contribute to microbial killing (Ohlsson et al, 1978).
Digestion of the killed microbes is mediated by the lysosomal proteinases which can
operate both intra- and extracellularly. Both acid and neutral proteinases can
contribute to the digestive process and are released by leukocytes in response to a
phagocytic stimulus (Leoni and Dean, 1983; Henson and Johnston, 1987). However,
digestion and elimination of microbes takes place largely intracellularly.
As previously described (1.3.), alveolar macrophages can also interact with lymphocytes
to trigger the adaptive immune response. In the alveolus, macrophages phagocytose the
invading pathogen and if the microbial insult is sufficiently intense, they may then
migrate to the lymph nodes where they are involved in antigen presentation to T
lymphocytes. This leads to clonal expansion of T- and B lymphocytes specific for antigens
of the invading pathogen, with associated cell-mediated cytotoxicity by T lymphocytes
and production of specific antibodies by B lymphocytes (Kaltreider, 1976).
1.4.3. Cellular profile of bronchoalveolar lavage leukocytes
Since its inception in the early 1970s, diagnostic bronchoalveolar lavage has been used
extensively in the detection and monitoring of disease states both clinically (Reynolds,
1987) and experimentally (Dethloff et al, 1987). The technique permits sampling of the
cellular and biochemical constituents present in the airspaces of the lung. The
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bronchoalveolar leukocytes are considered to be representative of the interstitial response
since the cellular profile of the bronchoalveolar cells is similar to those in the interstitium
in biopsy tissue (Hunninghake et al, 1979; Haslam et al, 1980: Nibbering et al, 1989). The
total number and differential count of the bronchoalveolar leukocytes are parameters
which yield vital information in the diagnosis and staging of inflammatory lung disease
(Reynolds,1987; Crystal et al,1981). The differential leukocyte count in normal
bronchoalveolar lavage varies from species to species but the predominant leukocyte type
is always the macrophage (Table 1).
Table 1. Proportions of leukocytes in normal bronchoalveolar lavage in different species.
Differential count (%)
Species Reference macrophages %neutrophils % lymphocytes
Human (1) 85 <1 7-12
Rat (2) 99 <1 <1
Monkeys (3) 91 4 5
Sheep (4) 84 2 14
Rabbits (5) 98 1 1
(1) Reynolds, (1987), (2) Donaldson et al, (1988a), (3) Idell et al, (1987), (4) Glauser et al,
(1988), (5) Shen et al, (1988)
1.4.4. Protection against injury to the host tissue
During breathing, the lung is continuously exposed to exogenous material. In order to
prevent excessive response to the constant tissue insult, the normal function of alveolar
macrophages is suppressive of immune and inflammatory responses (Holt, 1986) and
resident alveolar macrophages in normal lungs are not activated. Although one of the
functions of macrophages at other sites in the body is to present antigen to T lymphocytes
and so activate them, in vitro studies have shown that resident alveolar macrophages
reduce splenocyte proliferation (Kusaka et al, in press) and NK cell activity (Weissman et
al, 1986). When alveolar macrophages do become activated (e.g. by the process of
phagocytosis and killing of large numbers of microbes in the lung), the consequent release of
proteolytic enzymes and oxidants into the extracellular environment is potentially
hazardous to the host tissue (see 1.6.1 for further details).
Under normal circumstances "bystander injury" to the surrounding host tissue is prevented,
or substantially restricted, by protective mechanisms which limit the activity of the
released proteinases and oxidants. Antioxidant defences include catalase, a scavenger of
hydrogen peroxide, superoxide dismutase which inactivates superoxide anion, glutathione
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reductase and ceruloplasmin (Forman and Fisher, 1981; Aebi, 1984; Cantin and Crystal,
1985). Protection against proteolytic injury in the lung is thought to be mediated by a
cascade of antiproteinases (Morrison, 1987), the most prevalent of which is al-proteinase
inhibitor (al-PI), the major inhibitor of neutrophil elastase but not of macrophage
enzymes. a2-macroglobulin (a2M) inhibits both macrophage and neutrophil proteinases
(Travis and Salvesen, 1983), but it is a molecule of large molecular weight and is found in
very small amounts in normal alveoli. However, the alveolar concentration of a2M is
increased in lung inflammation due to both transudation from plasma and local production
by macrophages (Nathan, 1987). Other proteinase inhibitors in the lung include inter a-
trypsin inhibitor (Hochstrasser et al, 1972), al-antichymotrypsin (Ohlsson, 1978) and
antileukoproteinase (Kramps et al, 1988). Alveolar macrophages are involved in
antiproteinase defence through their ability to secrete al-PI (White et al, 1981a; Mornex
et al, 1986) and a2M (Hovi et al, 1977; White et al, 1981b).
1.5, Bronchoalveolar lavage leukocytes in inflamed lung
1.5.1. Cellular profile of the lavage leukocytes
The proportion and total number of the various leukocyte types in human bronchoalveolar
lavage are altered when inflammatory disease is present and this varies with the type
and stage of disease (Crystal et al, 1981; Rossi, 1986). In patients with active sarcoidosis,
the percentage of T lymphocytes may increase to around 40% (Thomas and Hunninghake,
1987), whilst in pneumonia there may be 70% neutrophils (Begin et al, 1986a). Other
chronic inflammatory lung diseases also show marked increases in the number and
proportion of neutrophils in bronchoalveolar lavage. In patients with rheumatoid lung and
cryptogenic fibrosing alveolitis and also in silicotics and asbestotics (Robinson et al, 1988),
the increase in neutrophils is accompanied by the appearance of eosinophils; in each case
the total number of leukocytes is also markedly increased. Experimental models of lung
disease have also revealed changes in the leukocyte profile of the lavage in rats (Morgan
et al, 1980; Dethloff et al, 1987 ; Donaldson et al, 1988a), rabbits (Shen et al, 1988),
monkeys (Idell et al, 1987), sheep (Begin et al, 1983) and hamsters (Verghese et al, 1988),
the most common response being increases in the total number of inflammatory leukocytes
and the proportion of neutrophils in the bronchoalveolar lavage.
1.5.2. Functional properties of bronchoalveolar lavage leukocytes
In addition to assessing changes in the cellular profile of bronchoalveolar leukocytes in
disease states, the functional properties of the leukocytes are frequently assessed and are
generally considered to be representative of the leukocytes of the entire lung parenchyma.
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Functional differences between interstitial and bronchoalveolar leukocytes do exist but
there are also many comparable features. Rat alveolar macrophages have been shown to
have increased IgG-Fc receptor expression and to exhibit enhanced ability to inhibit
splenocyte proliferation compared with interstitial macrophages (Holt et al, 1982).
Weissler et al (1986) reported that human bronchoalveolar macrophages were less
effective at stimulating a mixed lymphocyte reaction than macrophages from minced lung
but were of similar activity in interleukin 1 production and ability to present antigen. The
bronchoalveolar and interstitial populations were similar in expression of HLA-DR and
were of comparable maturity as determined by staining with the differentiation antigen,
M02. Nibbering et al (1989), using a panel of monoclonal antibodies, showed differences in
expression of some antigens between bronchoalveolar and interstitial macrophages in mice
infected with BCG but fewer differences in control mice.
Assessment of the functional properties of bronchoalveolar leukocytes has been used to gain
valuable information about the role of inflammatory leukocytes in lung disease, both
clinically and experimentally. Human bronchoalveolar macrophages in lung disease show
conflicting activities in the hands of different groups. They secrete increased IL-1 (Eden
and Turino, 1986), spontaneously secrete more alveolar macrophage-derived growth factor
(Bitterman et al, 1983) than control bronchoalveolar macrophages and yet have greater
ability to suppress autologous lymphocyte proliferation (Fireman et al, 1988).
Experimentally, altered bronchoalveolar leukocyte function has been expressed as reduced
spreading and chemotaxis in guinea pigs injected intratracheally with silica (Dauber et
al, 1982), decreased production of leukotrienes following smoke exposure in rats (Mobley et
al, 1987) and increased ability to cause epithelial injury following exposure to a variety of
mineral dusts (Donaldson et al, 1988b). Intratracheal injection of silica in rats leads to
impaired chemotactic responses of the bronchoalveolar leukocytes (Donaldson et al, 1989)
and increased IL-1 secretion ( Kusaka et al, in press).
1.5.3. Mechanisms of leukocyte recruitment
Small amounts of inhaled particles, including microbes, are constantly deposited in the
lungs. In the deep lung, this is largely dealt with by non-specific mechanisms involving
the alveolar macrophages, as previously described (1.4.2), but when the burden of extrinsic
material in the lung is excessive, leukocyte recruitment occurs and this results in
inflammation in the alveolar region (Donaldson et al, 1988a). The inflammatory response
is typified by increased alveolar epithelial permeability (Jones et al, 1982) and by
increases in the total number of macrophages and in the number and percentage of
neutrophils in bronchoalveolar lavage (Keogh and Crystal, 1982; Donaldson et al, 1988a).
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The increase in leukocytes is thought to arise largely by recruitment from the bloodstream
(Bowden et al, 1969) although local proliferation of macrophages may also account for
some of the increase (Tarling et al, 1987). Leukocyte recruitment occurs in response to a
chemotactic gradient such as that generated by microbial activation of complement (via
the classical or the alternative pathways), where C5a is the principal chemotactic agent.
Mineral dusts can also effect complement activation (Warheit et al, 1988) but to a much
lesser extent than microbes. Complement activation by mineral dusts may be the means
whereby the resident alveolar macrophages initially migrate within the alveoli to the
site of dust deposition. It is unlikely, however, that this is the main cause of leukocyte
recruitment in dust-inflamed lung since the degree of complement activation (measured by
generation of leukocyte chemotactic activity in serum) engendered by dusts in vitro, does not
correlate with their inflammogenic or pathogenic potential in vivo (K. Donaldson,
unpublished observation).
An additional source of chemotactic activity is from lung cells themselves and chemotaxins
are produced by activated macrophages (Herscowitz, 1985), neutrophils (Spilberg and
Mehta, 1979) and epithelial cells (Chauncey et al, 1988). Macrophages exposed to a
particulate stimulus in xntro release increased amounts of leukocyte chemotaxin (Lugano et
al, 1981), and bronchoalveolar macrophages from humans or animals with active lung
inflammation spontaneously secrete increased amounts of leukocyte chemotaxins in vitro (
Hunninghake et al, 1980; Wesselius et al, 1984; Schoenberger et al, 1982; Verghese et al,
1988). Following the initial burst of inflammation, other sources of leukocyte chemotaxins
may be generated if tissue injury occurs; dead cells (Privalova et al, 1980) and whole
molecules or breakdown products of the connective tissue components collagen,
(Postlethwaite et al, 1976), elastin (Hunninghake et al, 1981a; Senior et al, 1984), laminin
(Terranova et al, 1986) and fibronectin (Norris et al, 1982) are chemotactic for leukocytes in
vitro.
IL-1 and tumour necrosis factor (TNF) can enhance leukocyte recruitment to inflammatory
sites by upregulating adhesion molecules on the capillary endothelium (Pohlman et al,
1986) or attachment molecules on leukocytes (Hogg, 1989). This enhances margination of
leukocytes in post-capillary venules which is considered to be the first step in diapedesis
of the leukocytes from the bloodstream into the inflamed tissue (Malech, 1988). In
cigarette smokers, where there are increased numbers of leukocytes in the alveolar space,
smoking leads to an increase in the transit time for neutrophils passing through the
pulmonary capillaries (MacNee et al, 1989a). This could be taken as a general model for
the micro-circulatory events occurring during inflammation due to other agents where the
increased contact time between leukocytes and the capillary endothelium favours
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diapedesis and emigration. The physiological basis for the increased transit time has not
yet been fully revealed but decreased deformability of leukocytes, caused by cigarette
smoke or inflammatory mediators such as chemotaxins, could cause them to take longer to
negotiate the narrow alveolar capillaries (MacNee et al, 1989b). Decreased transit time of
leukocytes in dust-exposed lung has not, as yet, been demonstrated.
1.5.4. Macrophage activation in inflamed lungs
Macrophage activation is manifest as complex alterations in the structure, metabolism and
secretory status of these cells (Schneider and Dy, 1985; Johnston et al, 1986). Activated
alveolar macrophages show increased spreading on glass and release increased amounts of
oxidants, proteinases and cytokines; the latter can influence the functional status of other
cell types in the alveolus. Macrophage activation can be instigated by a variety of stimuli,
many of which are present in inflamed lung. Connective tissue components such as
fibronectin and chondroitin sulphates are released by proteolysis of the extracellular
matrix and are also secreted by activated macrophages (Rennard et al, 1981; Levitt and
Ho, 1983). This can, in turn, cause macrophage activation:- elastin peptides increase cell
movement and induce both oxidant and proteinase secretion in human monocytes (Fulop et
al, 1986). Collagen stimulates production of prostaglandins and a monocyte stimulating
factor in human monocytes (Dayer et al, 1982), acid hydrolase secretion and cytotoxicity to
tumour cells in resident mouse peritoneal macrophages (Schorlemmer et al, 1980) and
prostaglandin E2 and IL-1 production (Dayer et al, 1986) by human monocytes /
macrophages. Fibronectin enhances oxidant production in human monocytes (Kuroiwa et
al, 1988) and laminin enhances the phagocytic activity of human monocyte/macrophages
(Bohnsack et al, 1985). Neutrophils can enhance macrophage function through secretion of
IL-1 (Kusaka et al, in press) or a phagocytosis stimulating factor (Ishibashi and
Yamashita, 1987). Chemotaxins such as C5a (Banks et al, 1988), various phagocytic
stimuli (Schnyder and Baggiolini, 1978) and cytokines such as interferon gamma (Schultz,
1980), TNF (Beutler and Cerami, 1988), granulocyte macrophage colony stimulating factor
(Metcalf, 1985) and IL-1 Martin and Resch, 1988), elicit macrophage activation in vitro
and, in addition, many are secreted by activated macrophages (Dinarello, 1984; Metcalf,
1985; Nathan, 1987; Beutler and Cerami, 1988) thus a likely role for autoregulation of
macrophages in inflamed lung can be envisaged. The effects of such cytokines can be
synergistic (Billingham, 1987) and so, in inflamed lung where multiple inflammogenic
stimuli, including cytokines may be present, the potential for macrophage activation to
occur is likely to be great.
27
Alveolar macrophage activation has been demonstrated by various criteria in several
disease states; these criteria include expression of activation antigens (Agostini et al,
1987) and enhanced uptake of ^Gallium (Hunninghake et al, 1981b) in sarcoidosis and
hypersensitivity pneumonitis. Bronchoalveolar macrophages obtained from sarcoid
patients show increased secretion of IL-1 (Hunninghake, 1984) and gamma-interferon
(Robinson et al, 1985) in vitro. In the interstitial lung diseases there is evidence of increased
secretion of the alveolar macrophage-derived growth factor (Bitterman et al, 1983),
fibronectin (Rennard et al, 1981) and platelet derived growth factor (Martinet et al, 1987).
Alveolar macrophage activation has also been demonstrated experimentally as increased
spreading (Donaldson et al, 1984) and enhanced IL-1 secretion in rats exposed to silica and
asbestos (Oghiso and Kubota, 1986; Kusaka et al, in press). Increased oxidant production
has been described in hamsters similarly exposed to pathogenic dust (Hansen and
Mossman, 1987); chemotaxin secretion has been found in hamsters exposed to bleomycin
(Schoenberger et al, 1982) and arachidonic acid metabolism is increased in macrophages
from a rat model of lung granuloma (Kunkel and Chensue, 1983). In the milieu of inflamed
lungs, activated macrophages are likely, therefore, to play a major part in orchestrating
the development of the alveolitis.
1.5.5. Polymorphonuclear leukocytes in inflamed lung
The polymorphonuclear leukocytes are comprised of neutrophils, eosinophils, basophils
and mast cells; of these, the neutrophils are the body's main cellular defence against
invading microbes (Baggiolini and Dewald, 1985). Neutrophils are recruited to sites of
inflammation in response to chemotactic stimuli (see 1.5.3.). Once in the tissues they
undergo a process of activation, which is similar to that previously described for
macrophages (section 1.5.4.) and is mediated by chemotactic (Showell et al, 1976;
Snyderman and Goetzl, 1981) and phagocytic stimuli (Root and Metcalf, 1977; Baggiolini
et al, 1980), by inflammatory mediators (Shaw et al, 1981; Snyderman and Goetzl, 1981)
and by connective tissue molecules such as laminin (Terranova et al, 1986).
The process of activation triggers the release of various toxic products and inflammatory
mediators by the neutrophils. The toxic products are involved in microbial killing, a
violent process which can take place in the intra- or the extra cellular environments (see
1.4.2.). Neutrophils eliminate bacteria largely by means of two types of toxic product -
oxidants and proteinases (Baggiolini and Dewald, 1985). These have the capacity to
damage components of the host tissue and extracellular release of neutrophil oxidants
(Fantone and Ward, 1985) and proteinases (Reiser and Last, 1986) is considered to be a
major source of tissue injury in inflamed lung. Inflammatory mediators released by the
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neutrophils include products of the cyclo-oxygenase (Goldstein et al, 1978) and
lipoxygenase pathways (Smith et al, 1987), platelet activating factor (Betz and Henson,
1980) and IL-1 (Kusaka et al, in press; Tiku et al, 1986); all of these can further enhance the
inflammatory response by recruitment and activation of inflammatory macrophages and
neutrophils.
Eosinophils, basophils and mast cells are less commonly seen than neutrophils in
bronchoalveolar lavage from inflamed lungs but they do occur in some diseases. Cationic
proteins derived from activated eosinophils have been implicated in lung damage in
ARDS (Hallgren et al, 1987) and eosinophils have also been implicated in the
pathogenesis of pulmonary fibrosis (Peterson et al, 1987). Activation of basophils and mast
cells by IgE, with consequent release of inflammatory mediators is thought to play a part
in immunological diseases of the lung such as asthma and hypersensitivity pneumonitis
(Marone, 1985) but little is known of their role in non-immunological lung disease.
1.5.6. Lymphocyte populations in inflamed lungs
Alterations in the lavage profile of lymphocytes or lymphocyte subsets in pneumoconiosis
and bleomycin-exposed lung (Costabel et al, 1987; White et al, 1987) suggest that these
cells may be involved in the pathogenesis of lung disease where an immune component is
not immediately obvious. Lymphocytes, particularly T lymphocytes, may be involved in
lung pathology through secretion of gamma-interferon. This cytokine is a very efficient
activator of macrophages and can act synergistically with other cytokines such as IL-1 to
modulate the inflammatory response. Stimulation of lymphocytes to secrete gamma-
interferon occurs in response to antigen presentation in infected lungs. However, in a non-
antigenic inflammation, such as that produced by mineral dust exposure, the initiating
event for stimulation of lymphocytes may be secretion of IL-1 by activated macrophages
(Oghiso and Kubota, 1986) and neutrophils (Kusaka et al, in press).
1.6. Mechanisms of leukocyte-mediated injury in inflamed lung
All tissue cells depend on the extracellular matrix for physical support and to maintain
the microenvironment and structural integrity of the tissue. As in other tissues, the cells
and extracellular connective tissue of the lung parenchyma form a dynamic matrix that is
in a constant state of flux; both the cellular elements and the connective tissue are
continually degraded and renewed as part of the normal "housekeeping" of the lung
(Rennard and Crystal,1982). This constant renewal and replacement of the various
components of the lung parenchyma ensures their integrity and is thus vital in maintaining
the structure and function of the entire organ. In normal lungs, complex interactions between
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the leukocyte populations, the fixed cells (i.e. the epithelial, endothelial and
mesenchymal cells) and the connective tissue molecules of the lung parenchyma regulate
the metabolism and replication of the cells and this, in turn, governs the amount of
extracellular matrix that is deposited during normal connective tissue turnover and repair
of minor lung injury. In inflamed lungs, the release of toxic products by activated
macrophages and neutrophils causes injury to the delicate tissue of the alveolar septa and
consequent imbalance in these regulatory interactions. If the injury persists and the
connective tissue derangements become severe, this can result in permanently altered tissue
structure and function. Leukocytes also have the capacity to stimulate proliferation of the
fixed lung cells and to induce them to secrete connective tissue molecules. This has
beneficial consequences for the lung in repairing damaged tissue by restoring normal tissue
architecture. However, in pathologic conditions this type of stimulation may lead to
excessive proliferation of fibroblasts and scar tissue formation due to deposition of
excessive amounts or inappropriate types of connective tissue molecules.
1.6.1. Toxic products of inflammatory leukocytes
Inflammatory leukocytes release toxic products at sites of inflammation (see 1.4.2.) and
these have the capacity to cause "bystander injury" to the surrounding host tissue. The
most common types of injury are mediated by leukocyte proteinases and oxidants which can
injure both the fixed cells and connective tissue of the alveolar septa.
1.6.1.1. Leukocyte-derived oxidants.
In vitro studies have demonstrated that leukocyte-derived oxidants can mediate injury to
epithelial cells (Sugahara et al, 1986; Cantin et al, 1987) and endothelial cells (Harlan et
al, 1985; Martin and Kachel, 1985) and can also damage connective tissue molecules
(Audley and Chakrabarti, 1983; Monboisse et al, 1983; Riley and Kerr, 1985). Support for
the proposal that these toxic leukocyte products are important in the pathogenesis of
chronic inflammatory lung disease is found as increased oxidant production by
bronchoalveolar leukocytes in coalworkers with progressive massive fibrosis (Wallaert et
al, 1987) and in cigarette smokers (Hubbard et al, 1987). Confirmation that oxidant injury
leads to fibrosis comes from animal experiments where oxidant gases such as ozone cause
pulmonary fibrosis (Barr et al, 1988).
1.6.1.2. Leukocyte-derived proteinases.
Acid and neutral proteinases have also been implicated in the tissue injury associated
with inflammatory lung disease. Acid proteinases are released in large amounts to the
extracellular environment by inflammatory neutrophils and are found in increased amounts
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in bronchoalveolar lavage fluid from inflamed lungs (Donaldson et al, 1988c). Although
the extracellular milieu of the lung is usually maintained at neutral pH, local
accumulations of activated neutrophils may acidify the surrounding tissue by release of
granule contents and so permit the acid proteinases to act extracellularly (Davies and
Bonney, 1980).
Leukocyte neutral proteinases are currently thought to be the major source of tissue
proteolysis in inflamed lung. They are released in increased amounts by inflammatory
leukocytes in vitro (see 1.7.3-1.75) and are also increased in the bronchoalveolar lavage in
chronic inflammatory lung disease (see 1.7.7.). They have been shown to cause connective
tissue damage in vivo (Janoff, 1985; Snider et al, 1986) and in vitro (McDonald et al, 1979;
Werb et al, 1980) and also to mediate epithelial (Ayars et al, 1984; Sugahara et al, 1986;
Donaldson et al, 1988b) and endothelial cell injury (Vandenbroucke-Grauls et al, 1987).
A role for leukocyte neutral proteinases in the pathogenesis of chronic inflammatory lung
disease has been confirmed by the demonstration of emphysema in patients deficient in al-
PI, the major inhibitor of neutrophil elastase in the alveolar region (Laurell and Eriksson,
1963). Supporting evidence for the role of neutral proteinases in the pathogenesis of
emphysema arose from the finding that cigarette smoke oxidant gases could cause
oxidative inactivation of al-PI and might thus contribute to the increased prevalence of
emphysema in cigarette smokers (Janoff et al, 1980).
1.6.2. Consequences of extracellular matrix injury in inflamed lung
A primary function of the connective tissue matrix of the lung is to provide a scaffold for
the cellular elements. However, in addition, the actual conformation of the connective
tissue molecules in contact with the fixed lung cells may play a role in modulating the
response of the lung to injury. The integrity of the basement membrane is essential for
regeneration of normal tissue architecture in vivo (Vracko, 1972; Haschek and Witschi,
1979); this may be related to its function in acting as a support for replicating epithelial
cells or to specific interactions between the cells and matrix which govern cellular
proliferation (Lwebuga-Mukasa, 1986). Additionally, cell division and secretion of
connective tissue molecules may be regulated by the specific configuration of the connective
tissue (Martin and Kleinman, 1985). Several studies have shown altered properties of
fibroblasts (Aplin and Foden, 1985), epithelial cells (Sugrue and Hay, 1981), smooth
muscle cells (Holderbaum and Ehrhart, 1986) and endothelial cells (Ingber and Folkman,
1987) in response to connective tissue molecules and that work supports the theory of the
regulatory role of lung connective tissue in maintaining normal tissue architecture. A
further effect of connective tissue damage is the ability of connective tissue fragments to
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enhance the inflammatory response as described in section 1.5.3. Thus, besides impairing
the efficiency of gas exchange, damage to the connective tissue matrix of the alveolar
septa in chronic inflammatory lung disease may also play a major role in the pathogenesis
of the disease, by amplifying the inflammation and by interfering with the normal
regulation of connective tissue turnover.
1.63. Epithelial/mesenchymal-cell interactions in inflamed lung
Studies of epithelial-mesenchymal cell interactions in embryology have indicated that
direct cell-cell contact is an important factor influencing the normal growth and
development of the foetal lung (Adamson and King, 1985). It has been suggested that the
same mechanisms may be involved in the regeneration of epithelium on the alveolar
surface following lung injury (Bhandari and Powell, 1987). The proliferative status of Type
II epithelial cells is thought to be regulated (in part at least since macrophages may also
be involved) by direct cell to cell contact between alveolar epithelial cells and the
interstitial mesenchymal cells (Adamson and King, 1985). Chronic inflammatory lung
disease is frequently associated with basement membrane damage which then permits
increased contact between the alveolar epithelial cells and the mesenchymal cells of the
septal interstitium. The extent of the epithelial-mesenchymal cell interactions is thought
to be a predictor of the magnitude of subsequent mesenchymal cell proliferation (Witschi
et al, 1980; Brody et al, 1981 ) and may also influence the production of connective tissue
molecules by the interstitial fibroblasts. These mechanisms may be involved in the altered
connective tissue and mesenchymal cell profile of chronically inflamed lungs. The alveolar
lipoproteinosis and epithelial hyperplasia which characterises silicosis (Morgan and
Seaton,1984) may also be associated with alterations in cell to cell and cell to matrix
interactions following injury to the epithelium mediated by inflammatory leukocytes
(Donaldson et al, 1987b).
1.6.4. The role of inflammatory leukocytes in regulating the inflammatory
response in the lung
Leukocytes have several roles to play in modulating the inflammatory response in the
alveolar region. These are bacterial killing, removal of effete cells (Newman et al, 1982;
Duvall et al, 1985) and damaged connective tissue molecules (Carr, 1973; Etherington,
1980), and orchestration of the resolution of tissue injury. The latter is largely a function of
inflammatory macrophages and is mediated by secretion of regulatory cytokines
(Vaes,1985) and arachidonic acid metabolites (Henderson, 1987) as detailed in 1.5.4.
Other regulatory molecules secreted by macrophages include a factor that increases
monocytopoesis (FIMS) (Van Furth, 1988) and granulocyte/macrophage colony stimulating
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factor (Piacibello et al, 1985), both of which enhance monocyte and neutrophil recruitment
from the bone marrow. These molecules can act synergistically to stimulate or suppress
macrophage, neutrophil and fibroblast function in xritro, depending on the culture
conditions. They may thus play a central role in mediating connective tissue damage and
deposition in lung disease. Inflammatory macrophages secrete various factors which can
elicit fibroblast recruitment (Wahl and Wahl, 1981; Tsukamoto et al, 1981), proliferation
(Leibovich and Ross, 1976; Bitterman et al, 1982), secretion of connective tissue molecules
(Freundlich et al, 1986) and collagenase production (Huybrechts-Godin et al, 1985).
Macrophages can also downregulate fibroblast function by secretion of regulatory molecules
such as arachidonic acid metabolites (Metzger et al, 1986; Clark and Greenberg, 1987) and
through the action of IL-1 and TNF (Elias et al, 1988). Epithelial cell proliferation is also
modulated by macrophage cytokines (Kalina and Riklis, 1988). In addition, neutrophils
secrete regulatory molecules such as IL-1 (Kusaka et al, in press) (see 1.5.5.) and produce
factors which stimulate macrophage phagocytosis (Ishibashi and Yamashita, 1987) and
production of arachidonic acid metabolites (Henderson, 1987). T lymphocytes may also be
involved in the inflammatory response through secretion of gamma-interferon (1.5.6.).
All of the above may play a role in regulating the inflammatory response in the lungs.
Thus, though the alveolar macrophage is considered to be the predominant regulatory cell
in alveolar inflammation, other leukocytes may also contribute to the inflammatory
response through secretion of cytokines.
1.7. Leukocyte proteinases in tissue injury during acute and chronic lung
inflammation
Leukocyte proteinases play an important part in maintaining the normal structure and
function of the lung parenchyma by their ability to kill and digest bacteria. They also
digest and remove damaged host tissue prior to resolution or repair of injury and so
mediate the normal turnover of lung connective tissue (Senior and Campbell, 1983). Under
normal circumstances, the levels of proteinases in the alveolar region are low. This is
because there are few leukocytes present and these are comprised largely of non-activated
resident macrophages. During inflammation, the type and total number of leukocytes in
the alveolar region changes as large numbers of inflammatory macrophages and
neutrophils are recruited. This can lead to a gross increase in the burden of proteinase in
the lung parenchyma. However, there are mechanisms in the lung which protect against
proteolytic injury:- l)Many of the leukocyte proteinases are released as zymogens or
enzyme precursors which require activation before they can digest the tissue; 2)The
antiproteinase screen of the lung ( see 1.4.5.) forms a powerful defence against tissue
33
proteolysis by reacting with and inhibiting the majority of leukocyte neutral proteinases
released into the lung parenchyma. Notwithstanding the effectiveness of these protective
mechanisms, some "bystander injury" is an inevitable consequence of the accumulation of
large amounts of leukocyte proteinases during an inflammatory episode in the lung. In acute
inflammation, the tissue injury is resolved, with restoration of normal tissue architecture
and function; this is despite the recruitment of large numbers of inflammatory leukocytes
which may be up to 70% neutrophils in the case of some pneumonias (Begin et al, 1986a). In
chronic inflammatory lung disease, by contrast, the magnitude of the inflammation is
always less than in pneumonia, the leukocyte population in the bronchoalveolar lavage
comprising as few as 5% neutrophils (Begin et al, 1986a; Rom et al, 1987). Thus the
potential levels of proteinase and accordingly, tissue proteolysis, in the alveolar region
during acute inflammation are much greater than in chronic inflammatory lung disease but
pathological change generally accompanies only the latter. It appears, therefore that the
duration, rather than the magnitude of the inflammation can be the most important factor
in the development of pathological change. "Cumulative harm" may develop as each
individual, small tissue insult in the chronic disease state, is followed rapidly and
constantly by others, before the preceding injury has had time to resolve. This would
ultimately lead to tissue derangements of much greater severity in chronic disease than in
acute inflammation.
1.7.1. Initiation of proteinase secretion and potentiation of proteinase activity
Secretion of both acid and neutral proteinases is mediated largely by those processes
which are involved in leukocyte activation (1.5.4; 1.5.5), some of which are listed in Table
2 below. In addition, secretion of neutrophil proteinases can be instigated by a peptide
released from alveolar macrophages (Macarthur et al, 1987). Leukocyte proteinases,
secreted as inactive enzyme precursors can be activated by neutrophil oxidants (Weiss et
al, 1985), by an oxidant-independant process (Peppin and Weiss, 1986), by plasminogen
activator (Werb et al, 1977) and other neutral proteinases (Horwitz et al, 1976).
Table 2. Factors inducing proteinase release by leukocytes
Phagocytosis (Werb and Reynolds 1974)
Chemotaxins (Weissmann et al, 1975)
Lipopolysaccharide (Khar, 1986; Fittschen et al, 1988)
Immunoglobulins and C3 (Takemura andWerb, 1984; Henson, 1974)
Concanavalin A (Khar, 1986)
Fibronectin breakdown products (Wachtfogel et al, 1988)
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Colchicine (Werb, 1983)
Cyclic nucleotides (Weissmann et al, 1975)
IL-1 and TNF (Larrick and Kunkel, 1988)
Leukocyte proteinases, broadly classified as acid or neutral proteinases according to their
pH optima, have many functions in common but may also have divergent roles to play in
the milieu of inflamed lungs.
1.7.2. Leukocyte acid proteinases
The primary role of the acid proteinases is killing and digestion of microbes; this mainly
occurs intracellularly, within the acid environment of the phagolysosome, but there is
frequently some release of acid proteinases to the extracellular environment. This can occur
following cell death or as a result of the phagocytic stimulus being too large to be fully
internalised and thus the proteinases leak out of the incomplete phagolysosome (Fantone
and Ward, 1984). Transport of acid proteinases to the extracellular environment, in
response to specific stimuli, also occurs (Baggiolini and Dewald, 1985) and this may be a
mechanism whereby microbial killing can take place in the extracellular environment if
the concentration of the secreted lysosomal contents is sufficient to acidify the surrounding
tissue (Davies and Bonney, 1980). Leukocyte-derived acid proteinases can damage
connective tissue components of the lung (Vaes,1985) and so an unfortunate consequence of
extracellular microbicidal events may be "bystander injury" to the surrounding host tissue.
However, secretion of acid proteinases by inflammatory macrophages appears to be
largely confined to the early stages of inflammation (Fantone and Ward, 1984). This may
also be true of acid proteinase secretion by neutrophils and so the acid proteinases may not
be a major source of tissue injury in chronically inflamed lung, although they may have a
role to play in acute lung inflammation (Fels and Cohn, 1986). The neutral proteinases are
thought to be more likely arbiters of extracellular matrix damage (Carp and Janoff, 1983)
and recent work has concentrated on the role of these proteinases in such injury.
1.73. Neutral proteinases of neutrophils
The neutrophil neutral proteinases are largely contained within the azurophil granules of
the cell (Baggiolini et al, 1980). With the exception of collagenase, which is a
metalloproteinase contained within the specific granules in very small quantities, they
are all serine proteinases and therefore susceptible to inhibition by the major inhibitor in
the alveolar region, al-PI (Travis and Salvesen, 1983). The neutrophil enzymes are
generally considered to be preformed within the cells during maturation, prior to leaving
the bone marrow (Havemann and Gramse, 1984) with no synthesis taking place thereafter,
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except for plasminogen activator which is synthesised as required (Granelli-Piperno et al,
1977). However, there is one published report that intracellular elastase can be increased
by up to 100% in human peripheral blood neutrophils triggered in vitro with
lipopolysaccharide (Hart, 1984). The neutral proteinase content of neutrophils is
considerably greater than that of inflammatory macrophages (Janoff et al, 1979; Gadek et
al, 1984) and neutrophils have therefore been considered to be the major source of injurious
proteolytic activity in inflamed lungs. The predominant neutrophil proteinase is elastase,
a non-specific enzyme that can degrade most of the connective tissue molecules of the lung
parenchyma including elastin, collagen, fibronectin and glycosaminoglycans (Senior and
Campbell, 1983). The other major neutral proteinase of neutrophils is cathepsin G; this
enzyme can also degrade a variety of connective tissue molecules and can act
synergistically with elastase to potentiate tissue damage (Senior and Campbell, 1983).
Elastase activity can also be enhanced by plasminogen activator, through its action in
converting plasminogen to plasmin which is itself elastolytic(Chapman and Stone, 1984).
1.7.4. Neutral proteinases of macrophages
In comparison with neutrophils, inflammatory macrophages contain very low levels of
neutral proteinases and no cathepsin G; the enzymes are not stored preformed in the cells
but are synthesised and secreted in response to chemotactic, phagocytic or other
inflammatory stimuli (Senior and Campbell, 1983; Gadek et al, 1984). The major
macrophage neutral proteinases are plasminogen activator, collagenase and elastase and
these enzymes appear to act in concert to degrade the extracellular matrix (Werb, 1983).
With the exception of plasminogen activator which is regulated by specific inhibitors
(Hart and Rehemtulla, 1988) the mechanisms governing regulation of macrophage-derived
enzyme activity are not well characterised. Macrophage collagenase and elastase are
metalloproteinases (Werb et al, 1980) and so are not inhibited by al-PI but they are,
however, readily inhibited by a2M. This factor may be of importance to the role of
macrophages in tissue injury in chronically inflamed lung as discussed below.
1.7.5. Macrophage and neutrophil proteinases in tissue injury in inflamed lung
The relative contribution of macrophage and neutrophil proteinases to proteolytic injury of
the alveolar septa has received little attention, since for the reasons described above,
neutrophils are normally taken to be the main culprit in proteinase injury. Despite the
greater content of neutral proteinases in neutrophils, compared with macrophages,
proteinases from both cell types could have a role in eliciting tissue injury.
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There are two ways in which neutrophil enzymes are likely to be active in injuring the
alveolar septa, these are: (1) the concentration of proteinases may become so great, due to
neutrophil influx and degranulation, that the antiproteinase screen becomes overloaded
(Snider et al, 1986), or (2) at the site of close contact between the neutrophil and the septal
cells or connective tissue components, an exclusion zone could be formed such that
antiproteinases would not gain access (Johnson and Varani, 1981). Macrophage proteinases
are secreted in lower amounts on a per cell basis than those of neutrophils but since
inflammatory macrophages are generally present in much larger numbers than neutrophils
in chronically inflamed lung (Janoff et al, 1979), the levels of macrophage proteinases may
be increased sufficiently to render them of major importance to the disease process. In
addition, because they are not inhibited by al-PI, macrophage proteinases are more likely
to persist in an active state in the alveolar region than those of neutrophils. Although
there must be some means whereby released macrophage proteinases are inactivated in the
lung there is no evidence to date, of a specific inhibitor of macrophage proteinases in the
alveolar region. a2M readily inhibits macrophage proteinases and is secreted by
macrophages, although in very low amounts. It is ubiquitously present in plasma but is a
large molecule and does not cross the blood air barrier except as part of the inflammatory
exudate during acute inflammation. Thus, in chronically inflamed lung, macrophage
proteinases may contribute significantly to tissue injury.
1.7.6. Leukocyte neutral proteinases - proinflammatory and antiinflammatory
effects in the lung
In addition to their role in microbial killing via secretion of toxic products, leukocyte
neutral proteinases are involved in other aspects of host defense in the lung. These include
roles in modulating the inflammatory response by leukocyte recruitment and activation
and through tissue injury and repair during inflammation (see 1.5.2., 1.5.3. and 1.5.4.).
Neutral proteinases can also function in other ways to enhance or suppress the
inflammatory response. Secretion of plasminogen activator is thought to be a means
whereby leukocytes can regulate further leukocyte recruitment through the
proinflammatory effects of plasmin in the fibrinolysis, complement and clotting pathways
(Hamilton, 1980). Neutral proteinases can enhance leukocyte recruitment by direct
activation of complement components (Wright and Gallin, 1977; Johnston et al, 1976) and
cleavage of C-reactive protein to its chemotactic products (Robey et al, 1987). Proteolysis
of IgG produces a lymphocyte chemotaxin (Yamazaki et al, 1987) and al-PI is a
chemoattractant for neutrophils following proteolytic inactivation (Banda et al, 1988)
which may be mediated by a neutrophil metalloproteinase (Desrochers and Weiss, 1988).
Leukocyte neutral proteinases can also induce enhanced proteinase secretion (Werb and
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Aggeler, 1978) and oxidant production (Johnston et al, 1985) and can initiate lymphocyte
proliferation (Vischer et al, 1976). a2M-proteinase complexes have variously been shown
to instigate (Vischer et al, 1980) or suppress neutral proteinase release (Johnston et al,
1982) and to stimulate al-PI gene expression (Perlmutter et al, 1988). Prostaglandin
synthesis by macrophages can also be regulated by neutral proteinases (Chang et al, 1980).
From the foregoing studies it is apparent that leukocyte proteinases may play a major part
in orchestration of the entire inflammatory response in the lung.
1.7.7. Leukocyte proteinases in human lung disease
The theoretical role of leukocyte proteinases in the disease process, gained from
experiments in vitro, is given substance by the finding of increased levels of proteinase
activity in bronchoalveolar lavage fluid and leukocytes from patients with chronic
inflammatory lung disease. Elevated levels of collagenase have been demonstrated in
bronchoalveolar lavage fluid of sarcoidosis patients (O'Connor et al, 1988) and patients
with IPF (Gadek et al, 1979) and ARDS (Christner et al, 1985). Evidence of increased
neutrophil elastase activity has also been demonstrated in bronchoalveolar lavage fluid
of ARDS patients (Cochrane et al, 1983) and cigarette smokers (Janoff et al, 1983) and in
the plasma of cigarette smokers (Weitz et al, 1987). In addition, in vitro studies of
bronchoalveolar lavage leukocytes and peripheral blood neutrophils have also revealed
increased proteinase activity in leukocytes from cigarette smokers (Hinman et al, 1980)
and coalworkers (Hayem et al, 1980).
1.7.8. Rationale for the study of proteinases in experimental inflammatory lung
disease
The foregoing section of the thesis has documented the variety of ways in which leukocyte
proteinases can contribute to and sustain inflammation in chronically inflamed lungs and
indicates that they are likely to play a major role in the disease process through these
mechanisms. The role of inflammatory leukocytes in the disease process has been fairly
well elaborated in other types of chronic inflammatory lung disease but little work has
been done to investigate their role in the pneumoconioses. Leukocyte proteinases may be of
particular importance to the development of the emphysematous lesions which frequently
accompany the fibrotic changes in pneumoconiotic lungs. In addition, although much is
known about the type and amount of specific proteinases secreted by leukocytes, there has
been little work on the overall proteolytic activity of bronchoalveolar leukocytes. The
rationale behind the work contained in this thesis was therefore to combine an
investigation of the mechanisms of mineral dust-induced alveolitis with the development
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of an assay which would measure the ability of viable bronchoalveolar leukocytes from
dust-inflamed lungs to degrade connective tissue molecules.
1.8. Pathology of silicosis and coalworkers' pneumoconiosis
The main function of the lungs is gas exchange between the air and the blood. This involves
the transfer of oxygen and CO2 across the blood/air barrier and the structure of the
alveolar tissue is fully evolved for this purpose (Burri, 1985). The two main features of
lung tissue which contribute to the efficiency of gas exchange are:-1) the honeycomb-like
structure of the lung parenchyma which maximises the surface area of the lung and 2) the
structure of the alveolar septa. The walls of the septa are very thin and so minimise the
diffusion distance for oxygen and C02 between the alveolar space and the pulmonary
capillaries. In chronic lung disease, the efficiency of gas exchange becomes impaired when
the structure of the lung tissue is altered by the disease process. The predominant types of
lesion which occur in chronic lung disease are fibrosis and emphysema. These arise
following the tissue damage that occurs in chronically inflamed lung. Such damage is
currently considered to be mediated largely through the action of leukocyte-derived
oxidants and proteinases.
Fibrotic lesions are formed by excessive or inappropriate deposition of connective tissue
molecules and are characterised by thickening of the alveolar septa; in severe lesions this
may occlude the entire alveolus. The increased connective tissue component also alters lung
compliance and hence lung volumes are reduced. The major effect of such structural changes
is the development of ventilation / perfusion mismatch and this is the major source of
respiratory impairment in fibrotic lung disease. In addition, septal thickening increases
the diffusion distance of the blood/air barrier and this may also contribute to inefficient
gas exchange.
In emphysema, degradation of the connective tissue components of the alveolar wall leads
to loss of alveolar septa. This results in a decrease in the number of attachments which, by
traction, maintain the patency of small airways so these may close on expiration. The
consequent airflow limitation is the main cause of dyspnea in emphysematous patients but
additional contributing factors are the loss of surface area and elastic recoil of the lung
tissue
The current hypothesis concerning the pathogenesis of fibrosis and emphysema suggests
that despite their divergent outcomes these two pathological states originate in the same
manner with the development of alveolar inflammation. The pathogenesis of the two
disease processes is not yet fully elucidated but several additional hypotheses have been
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proposed to explain the divergent pathological responses of the lung tissue. The balance
between the destructive mechanisms which remove damaged or dead tissue and the
regenerative mechanisms which replace that tissue is necessarily a fine one. Tilting the
balance, even marginally in favour of repair mechanisms in chronic inflammatory lung
disease, could lead, in the long term, to the excessive accumulation of connective tissue.
Similarly, if tilted in favour of destructive processes, this would lead to the tissue loss
which is manifest as emphysema.
1.8.1. Human studies of silicosis and coalworkers' pneumoconiosis
Silicosis and coalworkers' pneumoconiosis are chronic fibrotic lung diseases associated
with exposure to silica and coalmine dust respectively (Morgan and Seaton, 1984). One of
the earliest demonstrations of disease associated with the presence of siliceous material in
the lungs at autopsy was published by Peacock in 1860; lung disease in coalworkers was
first described around the beginning of the 1800s (reviewed in Meiklejohn, 1951). Since
then, numerous other studies have also documented the relationship between silica and
coalmine dust-exposure and disease (Morgan and Seaton,1984).
The lesions of silicosis and coalworkers' pneumoconiosis are similar and can be
characterised on X-ray analysis by the International Labor Organization (ILO)
classification (Guidelines-ILO,1980) which relates category of disease to number and size
of lesions. At autopsy, the predominant lesions in both silicosis (Craighead et al, 1988) and
coalworkers' pneumoconiosis (Davis et al, 1983) are fibrotic nodules. In coalworkers'
pneumoconiosis, there is also evidence of extensive emphysematous change (Ruckley et al,
1984) and emphysema has been reported in silicotic lungs (Craighead et al, 1988).
Impairment of lung function in these diseases is associated with the degree of pathological
change; this is generally related to the extent of dust exposure but the disease may progress
even after exposure has ceased (Ruckley et al, 1984). The prevalence of silicosis and
coalworkers' pneumoconiosis in Great Britain has been markedly reduced in recent years by
control of dust levels (Morgan and Seaton, 1984) but problems do still exist, particularly in
the case of quarrying and the sandblasting of buildings, where there is currently no
legislation governing permissible levels of dust exposure. In developing countries,
occupational lung disease remains a major problem due to lack of effective dust control
procedures. In China, for example, around 10 million people are thought to be exposed to
silica and coalmine dust and between 600,000 and 800,000 pneumoconiosis patients were
registered in 1987 (Sjostrand, 1989).
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1.9. Factors contributing to the pathogenic potential of mineral
dusts
1.9.1 Pathogenic effects of silica
The commonest form of silica used commercially is alpha quartz which has a hexagonal
crystalline structure. Many recent studies have investigated aspects of the structure and
reactivity of quartz particles to determine how they exert their harmful effects. The
effects of crystal structure (Wiessner et al, 1988), particle number per unit weight (Ottery
and Gormley, 1978), and free radical content (Vallyathan et al, 1988) have all been
considered as possible factors modifying the biological reactivity of quartz. Current
concepts of the pathogenicity of silica are related to the surface activity of the particles
(Roggli et al, 1983). Crystalline silica is thought to form hydrogen bonds with the
phospholipid, protein and/or lipoprotein constituents of the cell (Iler,1978) leading to cell
death (Donaldson and Brown, 1988) or cell activation (Morgan et al, 1980). The release of
inflammation-enhancing material into the alveolar lumen, subsequent to either of these
cellular events would then cause recruitment of inflammatory leukocytes, with the
attendant consequences for tissue injury as previously described (see 1.5-1.7).
1.9.2. Pathogenic effects of coalmine dust
In common with quartz, the pathogenic potential of coalmine dust has previously been
attributed to its direct cellular toxicity (Gormley et al, 1980; Bowden and Adamson, 1984).
However, the biological reactivity of coalmine dust, unlike quartz, is complicated by the
fact that it is a mixed dust which contains many different minerals such as quartz, kaolin
and mica, each of which may contribute to the pathogenic potential of the dust. The quartz
content of coalmine dust has previously been considered to be of particular importance in
this respect but in vitro studies of the cellular toxicity of coalmine dust have failed to
establish correlations between quartz content and cytotoxicity (Gormley et al, 1980;
Seemayer and Manojlovic, 1980). Epidemiology studies have indicated that there is no
simple relationship between the quartz content of coalmine dust and its potential to cause
pneumoconiosis (Walton et al, 1977; Davis et al, 1977). These studies are backed up by
animal work which demonstrated a relationship between quartz content of dust and
pneumoconiotic potential only at levels of quartz exceeding 10% (Ross et al, 1962; Rotaru
and Lazarescu, 1982). Below 10%, the relationship between toxicity and quartz content is
variable. Where the toxicity of the coalmine dust is less than would be predicted by the
quartz content, the presence of minerals such as mica, though harmful in their own right
(Le Bouffant et al, 1977), may confer some protection against the more actively toxic
quartz. Such protection is thought to be mediated by the release of aluminium ions from
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mica and/or other minerals, which then coat the quartz particles and so reduce their
surface reactivity and biological activity (Le Bouffant et al, 1982). Evidence that the coal
component of coalmine dust is harmful in itself comes from epidemiology data showing
pneumoconiosis in anthracite areas, where the ash content of the coal is minimal (Hurley
et al, 1982), and animal inhalation studies which show inflammation in response to
anthracite (Donaldson et al, in press).
1.10. Previous experimental work investigating the role of inflammatory
leukocytes in the development of pneumoconiosis
Leukocytes have long been considered to play a central role in the pathogenesis of the
pneumoconioses. Initially, the resident alveolar macrophage was thought to play a key
role in tissue damage through release of acid lysosomal proteinases following cell death or
due to selective release of the enzymes. Much of the early work in this field concentrated
on the in vitro effects of mineral dusts on alveolar (Morgan and Allison, 1980) or peritoneal
macrophages (Davies et al, 1980), or on cell lines (Gormley et al, 1980).
With the advent of the technique of bronchoalveolar lavage it became apparent that, in
chronic fibrosing lung diseases of varying aetiology such as sarcoidosis, ARDS and IPF, a
common feature was the accumulation of large numbers of inflammatory leukocytes (both
macrophages and neutrophils) in the bronchoalveolar region (Hunninghake et al, 1979).
Functional studies of the bronchoalveolar leukocytes firmly implicated toxic products of
these cells in the disease process (See 1.6.1.). Subsequently, the emphasis in research into
the pneumoconioses shifted to assess the role of the inflammatory bronchoalveolar
leukocytes in the disease process and revealed that alveolitis was a feature that was also
common in these diseases (Voisin et al, 1985; Begin et al, 1986). Experimental studies
similarly began to assess the alveolitis in dust-exposed animals; in the majority of cases,
exposure by either intratracheal injection or by inhalation was used. The bronchoalveolar
leukocytes were then retrieved by lavage, counted and various functional parameters
studied. The earliest of this work was published by Bingham et al (1977) who found no
increase in the numbers of leukocytes in the bronchoalveolar lavage in rats inhaling
coalmine dust but substantial alveolitis following intratracheal injection of the dust. A
number of groups reported similar increases in total cells in the bronchoalveolar lavage
following intratracheal injection of silica in rats (Morgan et al, 1980), guinea pigs (Lugano
et al, 1982), mice (Callis et al, 1985), rabbits (Stankus and Salvaggio, 1987) and sheep
(Begin et al, 1987a). Similarly, alveolitis was also described following inhalation
exposure of rats to silica (Bolton et al, 1986; Donaldson et al, 1988a) and coalmine dust
(Donaldson et al, in press). An interesting feature of the inhalation studies was the finding
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that the bronchoalveolar leukocytes were greater than 90% viable. This indicates that, as
in the other chronic inflammatory lung diseases mentioned above, live cells are likely to
be important in bringing about pathological change in pneumoconiosis. Leukocyte
activation at the site of inflammation, with the attendant release of toxic products such as
proteolytic enzymes is likely to play a key role in the disease process (Hunninghake et al,
1979). This theory is supported by the finding that bronchoalveolar leukocytes from
patients with silicosis and coalworkers' pneumoconiosis secreted increased levels of
elastase in vitro (Hayem et al, 1980). Increased levels of elastase and collagenase were
also detected in the bronchoalveolar fluid in coalworkers' pneumoconiosis (Sablonniere et
al, 1983). Experimentally, increased levels of elastase have been demonstrated in the
lavage fluid of rats exposed to silica by intratracheal injection (Sykes et al, 1983).
However, there has been no systematic study of the mechanisms of proteolytic damage in
the lung following exposure to mineral dust. The purpose of the present study was therefore
to investigate the role of leukocyte-derived proteinases in the pathogenesis of
coalworkers' pneumoconiosis and silicosis.
1.11. Leukocyte proteinases and pneumoconiosis; the general hypothesis
The foregoing introduction has outlined the work and theories leading to the concept of a
central role for leukocytes in fibrosis and emphysema. In deriving a general aim for the
work described in this thesis an overview has been derived from many sources eg human
work, work with experimental animals and also with cells in vitro. The findings that 1)
some mineral dusts cause inflammation, 2) leukocytes accumulate in large numbers in
inflamed lungs and 3) they have the ability to attack elements of the lung connective
tissue led to the development of the general hypothesis to be tested in this work - namely





2. MATERIALS AND METHODS
2.1. The experimental model
The purpose of this study was to investigate some of the mechanisms whereby particles
deposited in the lung cause tissue injury, leading to permanent lung damage. To address
these questions, rats were exposed to a selection of particles, administered by inhalation
exposure or by injection directly into the lungs-intratracheal exposure. The leukocyte
response to particle deposition in the lung was assessed by lavaging the resected lungs and
counting the total number of leukocytes in the bronchoalveolar lavage fluid and by
measuring the the proportions of macrophages, polymorphonuclear leukocytes and
lymphocytes present. An assay of the ability of the bronchoalveolar leukocytes to
proteolytically degrade extracellular matrix was developed and validated. The
proteolytic activity of the bronchoalveolar leukocytes was assessed as a measure of their
potential to inflict injury on the delicate tissue of the alveolar septa.
2.2. Animals
Rats were obtained from the breeding unit of the Institute of Occupational Medicine. The
animals used were specific pathogen-free, syngeneic rats of the HAN or PVG strains,
housed in RB3 cages ( North Kent Plastics, Kent) and fed rat and mouse maintenance diet
number 1; water was supplied ad libitum. The animal rooms were maintained at a constant
temperature of 23-24°C, with a 12 hour photoperiod.
2.3. Particles
2.3.1. Particles used for intratracheal exposure
For the intratracheal experiments, the particles used were Corynebacterium parvum
(C.parvum, Wellcome Reagents Ltd., Hither Green, London) which is a heat-killed
bacterial preparation; zymosan (Sigma Ltd., Poole, Dorset)- a preparation of yeast cell
walls; the mineral dust, titanium dioxide (TiC>2, Tioxide Ltd., Stockton on Tees) and the
DQ12 quartz standard (quartz).
In some experiments the quartz particles were pre-treated with aluminium lactate
according to the method of Begin et al (1987b) as follows:- lOmg quartz was mixed by
rotation in 5ml of 1% aluminium lactate in distilled water for 3 hours at room temparature
and was then washed twice in 10ml saline, with centrifugation at 3000rpm following each
wash, to sediment the particles. (An MSE Super Minor centrifuge was used in this and all
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other experiments in this study). The washed particles were then resuspended in saline to
a concentration of 2mg/ml, prior to intratracheal injection of 0.5ml.
2.3.2. Coalmine dust used in the inhalation experiments
In the inhalation experiments, the dust used was a low-rank bituminous coalmine dust,
collected from the air of a British colliery using dry fabric Bondina filters (Robertson et al,
1984). On ashing, the coal dust contained 18.2% kaolin, 0.0% mica and 6.7% quartz; these
formed part of the 53.2% total ash in the dust. The dust was irradiated to kill microbial




Rats were anaesthetised by ether inhalation, the trachea was then exposed by dissection
and a small incision made to allow access of a blunt cannula which was inserted as far as
the first bifurcation of the bronchi. The particles were administered as a single bolus of
lmg in 0.5 ml saline or, in the case of C. parvum, 1.4 mg in 0.2 ml saline. Immediately
following the injection, the skin over the incision was closed with two 11mm Michel clips
(Albert Waeschle Ltd., Bournemouth) and the wound dusted with antibiotic powder
(Cicatrin, Wellcome Foundation, London). The entire procedure was completed within 5
minutes and the animals recovered with no ill effects.
2.4.2. Inhalation exposure
Rats were housed in a lm^ exposure chamber (Beckett, 1975) where they were exposed to
the respirable dust at an airborne mass concentration of lOmg/nA The coalmine dust used
in this study was generated as a cloud using a dust generator (Wright, 1950) and was then
passed into the chamber via the main ventilating airflow. The mass concentration of
respirable dust in the chamber was checked daily by measuring the amount of dust
collected onto the filters of a Casella MRE 113A dust sampler (Robertson et al, 1984). The
average dust concentration in the chamber over the period of the study, was within ±3% of
target (Donaldson et al, 1988c).
2.5. Lavage procedure for obtaining the bronchoalveolar
leukocyte population from rat lungs
Rats were killed by phenobarbitone overdose, administered by the intraperitoneal route.
The lungs and trachea were then exposed by dissection and the trachea cannulated with a
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blunt 16g syringe needle. Following resection, the lungs were lavaged with four sequential
O
8ml volumes of saline at 37 C, with gentle massage of the lungs on each wash to increase
the yield of cells. The recovered lavage fluid (5ml from the first lavage, 6-7ml thereafter)
was pooled in plastic universal containers and placed immediately on ice. The
bronchoalveolar lavage cells were pelleted by centrifugation at lOOOrpm, washed once in
30 ml of ice cold phosphate buffered saline (PBS) and resuspended in ice cold tissue culture
medium prior to use - the type of culture medium varied according to the assay procedure to
be used thereafter.
2.6. Bronchoalveolar leukocyte total count and differential
Total number of leukocytes was estimated by counting in a Neubauer chamber. Cells were
stained with trypan blue which confirmed that there were greater than 99% viable cells
in all of the populations tested. The relative proportions of macrophages,
polymorphonuclear leukocytes and lymphocytes were assessed by counting 100 cells per
sample in May Grunwald-Geimsa stained cytocentrifuge smears.
2.7. Proteolysis assay
The method for assessing the proteolytic activity of the bronchoalveolar leukocytes was
developed from the solid phase assay described by Campbell et al (1982) and detailed
below. Leukocytes or their supernatants were incubated on a matrix of iodinated
fibronectin, laminin or denatured collagen which was adhered in removawells (Dynatech
Ltd., Billingshurst, Sussex) or microtitre plates (Flow Labs Ltd., Irvine).
2.7.1. Substrate iodination
Rat tail (type I) collagen, bovine type IV collagen and human plasma fibronectin (all from
Sigma Ltd., Poole, Dorset) and mouse laminin (Gibco, Paisley) were iodinated by the
method of McConahey and Dixon, 1966, modified by substituting L-cysteine for sodium
metabisulphite. To 10(ig substrate in 10(il 0.25M phosphate buffer, pH 7.5, was added
500|iCi Na [^5 iodine]. 10|il chloramine T (2.5 mg/ml in phosphate buffer) were added and
mixed gently for 15 seconds. lOOjxl L-cysteine (0.6 mg/ml in phosphate buffer at a 1 in 5
dilution) were then added and again mixed gently before the final addition of 1ml
potassium iodide (5 mg/ml in phosphate buffer). Free ^iodine] was removed by
chromatography on a G25 sephadex column (PD10, Pharmacia-LKB Ltd., Milton Keynes,
Bucks) preequilibrated with PBS containing 0.05% bovine serum albumin (PBS/BSAXBSA-
Sigma Ltd, Poole, Dorset). The column was washed out with PBS/BSA and 0.5ml fractions
collected. Fractions forming the first peak, which corresponded to the iodine-labelled
substrate (Figure 1), were pooled and the radioactivity assessed by counting in a gamma
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counter (Pharmacia-LKB); the labelled proteins showed activities of 5-25 xlO^ cpm/pg
protein.
12-.
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Figure 1. Verification of the efficiency of fibronectin rad.ioiodinati.on. Points
represent total counts per minute in a 2pl aliquot of each 0.5ml fraction in a single
iodination. The iodinated substrate is contained in the first peak with the second
peak representing free [225iodine]. The proportion of 25iodine] that is protein-
bound is represented by the plot of TCA precipitable counts in the same 2pl samples.
The iodinated collagens were diluted in 0.1M acetic acid and lOOpl aliquots, containing
10,000 cpm for type I collagen and 60,000 cpm for type IV collagen were placed in microtitre
removawells and dried at 45°C, a temperature which denatures the collagen molecules;
iodinated laminin was diluted in saline to a concentration of 10,000cpm per 100pl which
was then dried in removawells as above. Fibronectin was diluted to a concentration of
40,000 cpm/lOOpl saline for the validation experiments and 60,000 cpm/lOOpl thereafter
and was dried onto wells of microtitre plates at 37°C. Drying of substrates onto plates took
place for 3 days. Prior to use, the wells were presoaked for two hours with 200(il of the
culture medium to be used in the assay and were then washed with 300|J.l saline to reduce
background counts.
2.7.2. Trichloroacetic acid-precipitation of iodinated proteins
In the initial experiments, the efficiency of the substrate trace-labelling procedure was
checked by trichloroacetic acid (TCA)-precipitation of each fraction obtained from the
Sephadex column. A 5|xl aliquot from each 0.5ml fraction was mixed in centrifuge tubes
with 50|il serum and 2ml of 20% TCA was then added to precipitate the protein. The tubes
were counted by gamma counter to estimate the total radioactivity present and were then
spun at 2000rpm to pellet the precipitated protein. The supernatant was discarded and
radioactivity in the pellet was compared with that in the whole sample prior to TCA
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precipitation (figure 1). In the pooled fractions containing the radiolabeled protein, >80%
of the pellet was TCA-precipitable, confirming that there was efficient trace-labelling of
the protein.
2.7.3. Coating efficiency for adherence of P^IJfibronectin onto
microtitre plates
To determine the efficiency of attachment of p25i]fjbronectjn to the wells, these were
prepared in the normal way (see 3.7.1.). Using this method 60,000 counts per well of
fibronectin were added to each well and dried on. The prepared wells were then presoaked
in N&T medium for 2hrs at 37°C prior to washing with 300pl saline. The washed
removawells were then counted by gamma counter to assess the total activity remaining
and from this, the specific attachment was found, on average, to be 60% of the original
counts added.
2.7.4. Proteolysis measurement
Cells, exogenous proteinases and inhibitors or triggers of proteolysis were added to the
matrices in a final volume of 200(il of tissue culture medium. Triplicate wells were set up
for each condition and were then incubated at 37°C; proteolysis was measured as amount of
iodinated substrate released into a 150)0.1 aliquot of the culture medium. Degradation of
[125i]_iabelled substrate was measured using a gamma counter to determine counts per
minute released. Apart from the experiment measuring the effect of increasing cell
number/well on proteolysis of fibronectin, cells were added at lx 10^ per well and in all but
those experiments which investigated the time-response of the assay, the duration of the
assay was 4 hours. In experiments to validate the proteolysis assay, the cells were cultured
in Newman and Tytell's medium (N&T, this and all other media were obtained from
Gibco-BRL Ltd, Paisley) containing 2% BSA (N&T/2%BSA). Thereafter, the medium used
was Ham's F10 containing 2%BSA (F10/2%BSA), except in the assays of collagen and
laminin proteolysis which were carried out in N&T alone.
2.8. Validation of the proteolysis assay
2.8.1. Proteolysis of fibronectin by exogenous enzymes
The ability of the assay to measure enzymic activity at neutral pH was assessed by
measuring proteolysis of fibronectin, collagen and laminin matrices by exogenous bovine
pancreatic trypsin (T8003), porcine pancreatic elastase (E0258) and bacterial collagenase
(C5138) (all enzymes obtained from Sigma Ltd, Poole, Dorset; catalogue numbers given in
brackets) at a concentration of lmg/ml. To further standardise the assay, dose response
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curves of the ability of the three enzymes to degrade fibronectin at concentrations ranging
from 0.0001 to 1.0mg/ml enzyme, were obtained using the fibronectin matrix.
2.8.2. The effect of specific proteinase inhibitors on fibronectin
degradation by exogenous proteinases
The ability of the assay to distinguish serine and metalloproteinases was assessed in the
fibronectin-proteolysis assay by determining the inhibitability of the proteinases by
specific inhibitors. Inhibition of elastase (serine proteinase) and collagenase
(metalloproteinase) by the serine proteinase inhibitor, al-PI at 0.01, 0.1 and 1.0 mg/ml
and the metalloproteinase inhibitor, disodium EDTA (EDTA - BDH, Glasgow) at 0.1, 1.0
and 10mg/ml was measured. This was accomplished by adding the above concentrations of
al-PI and EDTA to elastase and collagenase (lmg/ml) in the fibronectin degradation
assay.
2.8.3. Assessment of the effect of exogenous oxidants on the
fibronectin matrix
To verify the finding that leukocyte-derived oxidants were not involved in fibronectin
breakdown, exogenous oxidants were tested alone in the assay, at a concentration that
would be secreted by the leukocytes. Hydrogen peroxide (30%, Sigma Ltd, Poole, Dorset)
was diluted to a final concentration of 20 pMoles/well; 20pMoles of superoxide anion was
generated in the wells by adding 40mMoles acetaldehyde and 20(ig/ml xanthine oxidase.
2.9. The proteolytic activity of bronchoalveolar leukocytes
2.9.1. Dose-and time-response curves of fibronectin proteolysis by
bronchoalveolar leukocytes
Dose and time-response curves were carried out to validate the proteolysis assay, using
three bronchoalveolar leukocyte populations with markedly different cellular profiles -
C.parvum-elicited, quartz-elicited, and control leukocytes. The cells were incubated on the
fibronectin matrix at 0.001, 0.01, 0.1 and 1.0 xlO^ cells per well for 2, 4, 6 and 24 hours. The
experiment was performed in triplicate.
2.9.2. Degradation of laminin and denatured collagen types I and IV
by inflammatory leukocytes
The ability of control, C.parvum-elicited and quartz-elicited leukocytes to degrade
laminin and denatured type I collagen, was compared in three separate experiments using
microtitre plates coated with the iodinated substrates. The inflammatory leukocytes
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(C.parvum and quartz) were tested at 0.01, 0.1 and 1.0x10^ cells/well; controls were tested
at 0.01, 0.1, 0.5 and 1.0x10^ cells/well. Measurement of the proteolysis of type IV collagen
was carried out in a single experiment using 1x10^ C.parvum-elicited leukocytes/well as
lysed cells, cell supematants and intact, viable cells. Lysed cells were prepared by freezing
the cells rapidly in liquid nitrogen and thawing in a water bath at 37°C; this procedure
was carried out three times for each cell suspension. Supernatants were prepared by
culturing bronchoalveolar lavage leukocytes in microtitre wells for 4 hours; the
supernatant medium was then harvested, centrifuged for 5 minutes at 2500 rpm to pellet
cell debris and then tested immediately for ability to degrade denatured type IV collagen.
2.9.3. Proteolytic activity of bronchoalveolar leukocytes in the
presence of inhibitors of oxidants and proteinases
The proteolytic activity of bronchoalveolar leukocytes was measured in the fibronectin
proteolysis assay in the presence of the oxidant inhibitors, catalase and superoxide
dismutase (SOD) (both from Sigma, Poole, Dorset) and the proteinase inhibitors, al-PI
and a2M. The oxidant inhibitor concentrations were 0.01, 0.1 and 1.0 mg/ml and the
proteinase inhibitor concentrations were 0.01, 0.1 and 1.0 mg/ml for al-PI and 0.005, 0.05
and 0.5 mg/ml for ct2M. In one experiment the leukocytes were allowed to preadhere to the
fibronectin matrix before the inhibitors were added to assess the effect of exclusion of
inhibitors from the site of contact between cells and matrix.
2.9.4. The proteolytic activity of resident bronchoalveolar
macrophages and of macrophages and neutrophils separated
from a quartz-elicited bronchoalveolar leukocyte population
Separated populations of inflammatory macrophages and neutrophils were prepared from
quartz-elicited bronchoalveolar leukocytes, by density gradient centrifugation, using
Sepracell separating medium (Sepratech corporation, Oklahama, USA). Bronchoalveolar
leukocytes from a quartz-exposed rat (approximately 20 xlO^/rat) were washed, counted
and resuspended in 9ml saline. Three ml of the leukocyte suspension was added to 6 ml
Sepracell in a conical plastic centrifuge tube and mixed gently by inversion. The samples
were then centrifuged at 2600rpm for 20 minutes at room temperature after which the cells
appeared as two distinct bands; the macrophages were in a discrete layer at the top of the
separating medium and the neutrophils were at the bottom of the tube. The cells were
washed, counted and cytocentrifuge smears prepared for differential counting. The
proteolytic activity of each population was then compared, using a [^^^IJfibronectiri
matrix, with that of resident macrophages from the lungs of control rats.
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2.10. Human leukocytes-preparation procedure
2.10.1. Human bronchoalveolar lavage leukocytes
Human bronchoalveolar leukocytes were obtained by saline lavage of a patient with a
suspected chest infection who was undergoing routine bronchoscopy. The cells were washed
once in saline prior to differential counting and testing in the proteolysis assay.
2.10.2. Human peripheral blood neutrophils
Venous blood from a healthy non-smoking volunteer was withdrawn into a syringe
containing acid citrate dextrose. A leukocyte-rich plasma was obtained by Dextran
(Travenol, Thetford, Norfolk); MW70,000) sedimentation, followed by centrifugation at
1200 RPM for 10 minutes, on a discontinuous plasma-percoll (Pharmacia, Uppsala, Sweden)
(42 and 65%) gradient. This procedure resulted in a preparation whereby the mononuclear
cells were found in a layer on the surface of the separating medium, the neutrophils were in
a band that was 15mm below the mononuclear cells and the red blood cells pelleted at the
bottom of the tube. The neutrophil band was aspirated and contaminating erythrocytes
were lysed with 0.2% hypotonic saline, for 30 seconds, followed by reconstitution with
1.6% saline. The neutrophils were washed with PBS, total cells and differential were
counted and the cells were then resuspended in medium for testing in the fibronectin
proteolysis assay.
2.10.3. Human whole lung leukocytes
Whole lung leukocytes were obtained from a section of resected lung tissue which was
distal to a tumour. The tissue was chopped finely with scissors and squashed gently with a
glass homogeniser in a plastic universal. The finely minced tissue was then washed with
PBS, several times through a 100 gauge nylon filter (John Stanair & Co. Manchester). The
cells (5X10^) were resuspended in 20 ml PBS and then separated by layering 3 ml cell
suspension over 3.5 ml mono-poly resolving medium (Mono-poly - Flow Labs. Ltd., Irvine).
They were then spun at 1400 rpm for 40 minutes and the layer which formed at the
interface of plasma and separating medium was harvested. This contained a few
contaminating red blood cells which were lysed with red cell lytic buffer (NH4Cl-8.21g/L,
NaHCC>3-0.84g/L, disodium EDTA-0.336g/L, pH 7.2). The cells were washed twice in
PBS; total cells, differential count and proteolytic activity of the leukocytes were then
assessed.
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2.10.4. Assessement of the proteolytic activity of bronchoalveolar
leukocytes and peripheral blood neutrophils
Proteolysis of fibronectin by the two leukocyte populations was measured at 0.01, 0.1 and
l.OxlO^ cells/well. The ability of the two populations to respond to triggering was tested
by including phorbol myristate acetate (PMA-Sigma Ltd, Poole, Dorset) in the assay at
concentrations of 0.001,0.01 and 0.1 (ig/ml.
2.10.5. The proteolytic activity of leukocytes from excised lung
tissue
The dose and time response of the proteolytic activity of leukocytes obtained by mincing
excised lung tissue was measured in three separate experiments using the fibronectin
proteolysis assay. Cells were tested at 0.001, 0.01, 0.1 and l.OxlO^/well for times of 2, 4, 6
and 24 hours.
2.11. Comparison of inflammatory responses in the
bronchoalveolar region, elicited by different particles injected
into the lung
The inflammatory response to 1.2mg of C. parvum or lmg of zymosan, TiC>2 or quartz was
measured following intratracheal exposure at intervals of 1, 3, 5 15 or 30 days after
injection. Total cells in the lavage, differential count and the ability of the
bronchoalveolar leukocytes to degrade fibronectin were measured at each time point. The
ability of the bronchoalveolar leukocytes to respond to in vitro triggering was measured in
the fibronectin proteolysis assay. The triggers used were PMA at 0.1,1.0 and 10 pg/ml and
zymosan, TiC>2 and quartz at 0.01,0.1 and 10 mg/ml. In some experiments, these were added
into the proteolysis assay at the same time as the cells; in others, the leukocytes were
cultured for three days in the presence of the triggers and proteolytic activity released into
the supernatant medium was measured.
2.12. Coal inhalation expts.
Rats were exposed to lOmg/m^ of airborne coalmine dust (see 2.4.1.) for 7 hours per day, 5
days per week. On days 8,16 or 32 of dust exposure, groups of 4 rats were removed from the
chamber, killed and the bronchoalveolar leukocyte population obtained by lavage. At
each time point, 2 control rats of identical age, maintained in room air were also lavaged.
One group of four rats was removed from the chamber on day 32 of dust-exposure and
maintained in room air for a further 64 days before being lavaged; these will be referred to
as "recovery" animals. The inflammatory effect of the coalmine dust was measured as
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total and percentage neutrophils in the bronchoalveolar lavage. Proteolytic activity of
the bronchoalveolar leukocytes was measured in the fibronectin degradation assay. The
proteolytic activity of leukocytes obtained 8 days after the start of dust exposure was
measured in the presence of triggers and inhibitors of leukocyte proteolytic activity. The
triggers used were PMA (0.1, 1.0 and 10 pg/ml) and zymosan (1,10 and 100 pg/ml);
inhibitors were al-PI (0.01, 0.1 and 1.0 mg/ml), ot2M (0.005, 0.05 and 05 mg/ml), foetal calf
serum (FCS-Gibco-BRL, Paisley;l, 5 and 10%) and EDTA (0.01,0.1 and 1.0 mg/ml).
2.13. Assessment of the effect of aluminium lactate on the
biological reactivity of quartz
Native quartz particles and quartz particles which had been pre- treated with aluminium
(see 2.3.1.) were injected intratracheally. The inflammatory response to particle
deposition and the proteolytic activity of the bronchoalveolar leukocytes were measured
at intervals of one, four or twelve weeks thereafter. To address the mechanisms whereby
the aluminium lactate might react with the quartz particles, two further experiments
were performed: 1) 50|ig of aluminium lactate in 0.5ml saline was administered to the rats
by intratracheal injection, one month after injection of the quartz. Bronchoalveolar lavage
of these animals was performed after a further 1 week or 1 month and the total and
differential count and proteolytic activity of the leukocytes were measured, 2) To assess
the specificity of the aluminium lactate treatment, rats were exposed to C. parvum and
50(ig of aluminium lactate, administered at the same time. The inflammatory response was
then measured as before, 1, 3 and 15 days after injection.
2.14. Histological preparations
Lungs treated with quartz or quartz/aluminium lactate were fixed after lavage by
inflating with 10% formol saline prior to routine processing for histology. Whole lung
sections were cut by microtome and stained with haematoxylin and eosin to visualise the
tissue. Some of the sections were stained with reticulin to show up reticular collagen
deposition.
2.15. Statistical analysis
Data from the early experiments validating the proteolysis assay with exogenous
proteinases, and measuring dose and time responses for matrix proteolysis by
bronchoalveolar leukocytes were evaluated by analysis of variance using the Minitab
statistical package. In all other experiments, differences between means of treatment





3.1. Validation of the proteolysis assay
The aim of this thesis was to investigate the potential of inflammatory leukocytes to
cause connective tissue damage in inflamed lungs. This question was addressed by
measuring the ability of viable leukocytes to damage connective tissue molecules in vitro,
through the action of neutral proteinases. The proteolytic activity of bronchoalveolar
leukocytes was assessed by measuring their ability to degrade iodinated connective tissue
components, adhered as a solid phase matrix in microtitre plates. The experiments in this
part of the thesis were designed to develop and standardise the proteolysis assay prior to
addressing the key questions of the thesis.
3.1.1. Matrix degradation by exogenous proteinases
Before commencing the leukocyte work, preliminary experiments were carried out to test
the suitability of the proteolysis radioassay for detection of neutral proteinase activity.
The proteolytic activity of exogenous collagenase, elastase and trypsin was assayed using
iodinated laminin, fibronectin and denatured collagen matrices. The specificity of the
assay in identifying different classes of enzyme was tested by measuring the ability of
specific inhibitors of metalloproteinases and serine proteinases to inhibit proteolysis of
fibronectin by collagenase (metalloproteinase) and elastase (serine proteinase).
3.1.1.1. Proteolysis of fibronectin, laminin and denatured collagen by exogenous
proteinases
Microtitre plates coated with iodinated laminin, fibronectin or denatured type I collagen
were incubated with lmg/ml of collagenase, elastase or trypsin in F10/2%BSA. Each
enzyme caused significant proteolysis of all matrices (p<0.005 compared with medium
alone) (Table 3). Elastase was the most active and collagenase the least so but this does not
reflect the true relative proteolytic activity of the three enzymes, since they were assayed
according to weight and not enzyme activity.
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Table 3. Proteolysis of laminin, fibronectin and denatured collagen, matrices by exogenous






Collagenase 2963(165) 4736(1311) 2904(726)
Elastase 3193(394) 7170(529) 3761(367)
Trypsin 2947(181) 6092(743) 3622(217)
None 885(156) 1399(119) 655(102)
Results are presented as counts of [1251]-degradation products released and are the
mean(sd) of three wells per sample in two separate experiments.
The proteolytic activity of all three enzymes was dose-dependant as shown in Table 4,
using a fibronectin matrix and, in a further single experiment, was abolished by dilution to
low concentrations (0.1,0.01,0.005 and 0.001 mg/ml, Figure 2).
Enzyme concentration (mg/ml)
Figure 2. Dose response of fibronectin proteolysis by exogenous enzymes; enzyme
concentrations are given in mg/ml. Results are the mean(sd) of triplicate wells in
four separate experiments.
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Table 4. Dose-dependent proteolysis of fibronectin by exogenous collagenase, elastase and





0.01 3859(669)* 7245(647) 9805(332)
0.1 6063(635) 8667(945) 10844(905)
1.0 7076(524) 10600(890) 11601(872)
* Background counts (no enzyme, 1539(160)) have not been subtracted from the absolute
counts.
The increase in proteolysis with increasing enzyme concentration was significant at all
concentrations for collagenase and elastase (p<0.005). Trypsin had greater proteolytic
activity than collagenase or elastase at 0.01 and 0.1 mg/ml but showed less of a dose-
dependant change, the only significant increase in proteolysis being between 0.01 and 0.1
mg/ml (p<0.01). The lack of a significant dose response with trypsin, which had the
greatest activity at all concentrations, may be because at that enzyme activity, the plates
were near to the limit of their capacity to detect proteolysis.
3.1.1.2. Inhibition profile of collagenase and elastase
Inhibition of lmg/ml collagenase and lmg/ml elastase by EDTA at 0.1, 1.0 and 10 mg/ml
and by al-PI at 0.01, 0.1 and 1.0 mg/ml was measured using the fibronectin matrix (Figure
3).
Figure 3. Dose response of the metalloproteinase inhibitor, EDTA and the serine
proteinase inhibitor, alPI in reducing fibronectin proteolysis by the exogenous
metalloproteinase, collagenase and the serine proteinase, elastase. Results are the
mean(sd) of triplicate wells per sample in two separate experiments. Inhibitor
concentrations:- al-PI, 0.01, 0.1 and 1.0 mg/ml; EDTA, 0.1, 1.0 and 10 mg/ml
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EDTA caused dose-dependant inhibition of eollagenase that was significant at all
concentrations (O.lmg/ml p<0.01,1.0 mg/ml p<0.005,10 mg/ml p<0.0005) but the reduction
in elastase activity which occurred only at 10 mg/ml EDTA was not significant.
Conversely, there was no significant reduction of collagenase activity at any concentration
of al-PI but elastase activity was significantly inhibited by 1.0 mg/ml al-PI (p<0.0005).
3.1.2. Matrix degradation by bronchoalveolar leukocytes
The assay was further standardised by using in the main, three bronchoalveolar leukocyte
populations. These populations were control cells, C.parvum-ehcited cells and quartz-
elicited cells (Figure 4a-c). These were of varying neutrophil content (Table 5) and since
neutrophils constitutively contain greater levels of neutral proteinases than macrophages,
were therefore likely to contain different amounts of neutral proteinase. TiC>2-elicited
bronchoalveolar leukocytes obtained 5 days after intratracheal injection, were also used in
some of the experiments in this part of the study; this TiC>2 population contained 2%
neutrophils.
The dose and time response of the proteolytic activity of control and inflammatory
leukocytes was established using a -^^1]fibronectin matrix. Proteolysis of iodinated
laminin and denatured type I, and type IV collagen matrices by the leukocytes was also
assessed using a single concentration of the cells.
Table 5. Differential count of bronchoalveolar leukocytes from control, C.paTvum-elicited and
















Figure 4. Bronchoalveolar leukocytes from a.) control rats, b.) rats exposed to
C.parvum for 16 hours prior to lavage or c.) rats exposed to quartz 5 days prior to
lavage.
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3.1.2.1. Proteolysis of fibronectin by bronchoalveolar leukocytes
The ability of all three populations to degrade a fibronectin matrix increased with
increasing cell number (Figure 5); this was true at 2,4, 6 and 24 hours (Table 6) but only the
6 hour time point is presented in the figure for clarity.
5
Calls per well x 10
Figure 5. Dose response of fibronectin proteolysis by bronchoalveolar leukocytes (6
hour time point). Results are the mean(sem) of triplicate wells per sample in three
separate experiments.
At 6 hours, the release of [^^1] fibronectin-degradation products by control and quartz
populations was significantly greater than background at concentrations of 0.1 and 1.0 x 10^
cells/well (controls p<0.0025 and p<0.005 respectively; quartz pxO.005). The difference
between the control and quartz leukocytes reached statistical significance at 1.0 x 10^
cells/well (p<0.0005). C. parvum-elicited cells were significantly more active than control
leukocytes at 0.01 x 10^ cells/well and above (p<0.005). The C. parvum-elicited cells
consistently had greater proteolytic activity than the quartz cells but the difference
between the two populations reached statistical significance only at 0.1 x 10^ cells/well
(p<0.005).
Proteolysis of fibronectin by control, C. parvum and quartz-elicited cells increased with
time (Figure 6). Only the results obtained using 1x10^ cells/well are shown in the figure for
clarity but the time response was also present at 0.01 and 0.1 xlO^ cells per well (Table 6).
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Table 6. Dose and time response of fibronectin proteolysis by control, C.parvum and quartz-
elicited leukocytes. Results are the mean(sd) of three wells per sample in three separate
experiments.
Leukocyte Time Number of cells/well (xlO5)
population (hrs) 0 0.001 0.01 0.1 1.0
Control 2 X 532 613 603 781 1781
sd 145 171 120 112 412
Control 4 X 745 831 892 1112 2548
sd 84 148 157 274 669
Control 6 X 916 1223 1473 2769 5453
sd 149 176 511 1754 2646
Control 24 X 1647 1962 1975 2827 5901
sd 240 283 418 1006 2035
C.parvum 2 X 532 657 927 2305 5458
sd 145 123 101 294 983
C.parvum 4 X 745 841 1585 3603 7605
sd 84 88 103 450 990
C.parvum 6 X 916 1142 2232 4915 9419
sd 149 248 242 264 1102
C.parvum 24 X 647 2695 4643 8785 13599
sd 240 230 328 876 923
Quartz 2 X 532 612 759 1184 3396
sd 145 85 136 153 832
Quartz 4 X 745 1020 1163 2393 5876
sd 84 92 96 487 798
Quartz 6 X 916 1183 1403 3069 8031
sd 149 129 150 576 492
Quartz 24 X 647 2639 3849 8607 11728
sd 240 212 367 745 853
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Time (hours)
Figure 6. Time response of fibronectin proteolysis by bronchoalveolar leukocytes
(lxl05/well). Results are the mean(sem) of triplicate wells per sample in three
separate experiments.
At 1 x 105 cells/well each population caused significantly (p<0.025-p<0.005) greater
release of counts than medium alone at every time point. Both inflammatory populations
were significantly more active than controls at each time point (p<0.01-p<0.005) and
similarly, the C.parvum cells were significantly more active than the quartz cells at all
time points (p<0.025-p<0.005).
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3.1.2.2. Proteolysis of denatured collagen and laminin
All three cell populations had dose-dependent activity in degrading denatured collagen
and laminin matrices (Figure 7A and 7B).
Cells per well x 105
Fig 7a
Cells per wellx 105
Fig 7b
Figure 7a and b. Dose response of denatured collagen (fig a) and laminin (fig b)
proteolysis by bronchoalveolar leukocytes at lxlO^/well. Results are the mean(sd) of
triplicate wells in a single experiment.
In [125i]coiiagen_coateci microtitre plates, at 1x10^ cells/well, counts released into the
supernatant medium by all three populations, were significantly greater than those
released by medium alone (controls p<0.01, C.parvum and quartz p<0.001). Using
[125i]iaminin-coated plates the results were similar at 1x10^ cells/well (significantly
different from medium alone:- controls, C.parvum and quartz p<0.001). Proteolysis of both
matrices by the C.parvum and quartz leukocytes was also significantly greater than
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background at 0.1x10^ cells/well (p<0.001) but there was no significant difference between
medium alone and control leukocytes at 0.1x10^ cells/well. Quartz and C.parvum
leukocytes had significantly greater ability to degrade both matrices than control
leukocytes at 0.01, 0.1 and l.OxlO^ cells/well (p<0.005). The C.parvum-elicited leukocytes
were more active in degrading both types of matrix than the quartz cells at all
concentrations but the difference did not reach statistical significance. Thus, the three
populations had different proteolytic activity which reflected, in part, the number of
neutrophils in each.
3.1.2.3. Proteolysis of type IV collagen by intact inflammatory leukocytes, lysed
cells and cell supernatants
C.parvum-elicited inflammatory leukocytes caused marked proteolysis of type IV collagen
































Figure 8. Proteolysis of type IV collagen by C.parvum-elicited bronchoalveolar
leukocytes as intact cells, lysed cells or 24 hour supernatants of the cells. Results are
the mean(sd) of triplicate wells in a single experiment and are compared loith the
proteolytic activity of porcine pancreatic elastase tested in the same experiment.
The activity of the C.parvum cells was equivalent to between 0.1 and 0.01 mg/ml elastase
(7306(208) and 3426(115) respectively). Intact leukocytes had significantly greater
proteolytic activity than lysed cells (4768(158), p<0.01). Leukocyte supernatants were
produced separately in a 4 hour period, under the same conditions as those used in the
assay. These had significantly less ability to degrade fibronectin (2412[136]) in 4 hours,
than intact leukocytes or lysed cells (p<0.0005).
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3.13. Summary
The experiments presented in this section of the thesis served to demonstrate that the
experimental protocol was sound. The techniques of intratracheal injection and
bronchoalveolar lavage yield leukocytes of different cellular and functional profiles
depending on the injected material and are therefore valuable tools in studying the
leukocyte response of the lung to deposited exogenous material. The proteolysis assay is
capable of detecting the main enzymes of interest, that are likely to be of importance in
causing proteolytic damage in the lung ie collagenase and elastase. The two enzymes can be
distinguished by their different inhibition profiles in response to specific inhibitors of
serine and metalloproteinases. The assay also distinguishes the activity of different
bronchoalveolar leukocyte populations in a cell number- and time-dependent manner.
Inflammatory bronchoalveolar leukocytes were more active than controls in degrading
fibronectin, collagens type I and IV and laminin. The proteolytic activity of intact cells
was greater than that of lysed cells (which contained all cell fragments) or cell
supernatants which suggests that part of the activity of intact leukocytes may be due to de
novo enzyme synthesis over the 4 hours of the assay.
3.2. The effect of inhibitors of oxidants and proteinases on
fibronectin degradation by bronchoalveolar leukocytes
Both oxidants and proteinases have hitherto been shown to damage connective tissue
molecules and so the role of these leukocyte-derived products in causing proteolysis of
fibronectin by control, quartz and C.parvum-elicited leukocytes was assessed by the use of
specific inhibitors.
3.2.1. The effect of antioxidants on fibronectin degradation by control and
inflammatory bronchoalveolar leukocytes
To assess the role of leukocyte-derived oxidants in fibronectin proteolysis, leukocytes were
cultured on a fibronectin matrix in the presence of the antioxidants superoxide dismutase
and catalase; these scavenge superoxide anion and hydrogen peroxide respectively. There
was no significant reduction in fibronectin proteolysis by either superoxide dismutase or
catalase at concentrations of 0.01, 0.1 or 1.0 mg/ml (Figure 9).
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Inhibitor concentration ^.g/rnl
Figure 9. Proteolysis of fibronectin by control, C.parvum and quartz-elicited
bronchoalveolar leukocytes in the presence of the hydrogen peroxide inhibitor,
catalase and the scavenger of superoxide, superoxide dismutase. Results are the
mean(sem) of triplicate wells per sample in three separate experiments,
(cat = catalase, sod = superoxide dismutase)
This result suggested that leukocyte-derived oxidants played no part in matrix
degradation in this assay. Exogenous hydrogen peroxide and superoxide were therefore
tested in the assay. A dose of 20pM was used for each oxidant as this is approximately the
amount that would be produced by leukocytes in culture. The exogenous oxidants also failed
to cause matrix degradation (medium alone-2986[85])(mean[sem]counts per minute
[125i]fibronectin degraded); superoxide dismutase-2058(56); hydrogen peroxide-1858(78))
and thus confirmed the finding that leukocyte-derived oxidants are not involved in matrix
degradation in this assay.
3.2.2. The effect of proteinase inhibitors on fibronectin proteolysis by control
and inflammatory bronchoalveolar leukocytes
To assess the role of individual proteinases in matrix degradation, the inhibitor profile of
the leukocytes was obtained using al-PI and a2M, two inhibitors which are present in
varying amounts in the alveolar region of the lung. In most of the experiments assessing the
inhibitor profile of the bronchoalveolar leukocytes, the cells and proteinase inhibitors
were added together to the wells. However, leukocytes in the lung are likely to be in close
contact with the connective tissue matrix. It is possible that at the site of close contact
between cells and matrix, an exclusion zone might be formed where molecules of large
molecular weight, including proteinase inhibitors, could not gain access. In order to test
this hypothesis, leukocytes from control, TiC>2- or quartz-treated rats were used. The
bronchoalveolar leukocytes were preincubated on a fibronectin matrix prior to addition of
al-PI and then inhibition of matrix proteolysis was measured as previously.
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3.2.2.1. Inhibitor and leukocytes added to wells at the same time
The proteinase inhibitors, al-PI and a2M minimally inhibited control cell proteolysis of
fibronectin; the inhibition was neither significant nor dose-dependant. Both inhibitors did
cause inhibition of the two inflammatory populations (Table 8) when added at the start of
the assay. al-PI was equally effective in inhibiting both the C.parvum and the quartz
cells, with significant reductions of proteolysis at 0.1 and 1 mg/ml (jxO.OOl) and at 0.01
mg/ml (p<0.01). a2M also significantly reduced fibronectin proteolysis by the quartz-
elicited cells at 0.05 mg/ml (p<0.05) and at 05 mg/ml (p<0.001) but was less effective in
reducing C.parvum-mediated proteolysis of fibronectin, achieving a significant reduction
only at a concentration of 0.5 mg/ml (p<0.001).
Table 8. Degradation of fibronectin by control, C. parvum and quartz bronchoalveolar
leukocytes in the presence of the proteinase inhibitors, al-PI and a2M. Results are the
mean(sem) of triplicate samples in three separate experiments.
LEUKOCYTE POPULATIONS
Inhibitor Conc.(ug/ml) Control C.parvum Quartz
0 2603(299) 4587(456) 5108(304)
al-PI 0.01 2380(251) 2885(569)** 3963(374)**
0.1 2428(261) 2795(379)*** 3260(335)***
1.0 2333(235) 2097(230)*** 2531(274)***
a2M 0.005 2787(321) 4298(418) 4648(335)
0.05 2456(281) 4157(571) 4198(348)**
0.5 2286(288) 3528(418)*** 3534(275)***
** Significant reduction compared with no inhibitor, p<0.01
*** Significant reduction compared with no inhibitor, p<0.001
Background counts (no cells, 1679(69)) have not been substracted. N.B. The inhibitor
profiles of C.parvum and quartz leukocytes were assessed at different times so, because of
half life effects with the [^^1], the proteolytic activity of each is not directly
comparable.
3.2.2.2. Preadherence of leukocytes to a fibronectin matrix: effect on the inhibitory
capacity of al-PI
When control, Ti02- and quartz-elicited leukocytes were added to a fibronectin matrix at
the same time as al-PI this led to a significant inhibition of proteolysis over the 4 hours of
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Figure 10. Effect of preadhering TiOz and quartz-elicited bronchoalveolar
leukocytes to the fibronectin matrix, on the inhibitory capacity of al-PI in the
proteolysis assay. Results are the mean(sem) of triplicate wells in a single
experiment.
However, when the leukocytes were allowed to preadhere to the matrix for 30 minutes
prior to addition of al-PI, there was no significant reduction in the proteolytic activity of
any of the cells in the subsequent 4 hours.
3.2.3. Summary
The foregoing results indicate that leukocyte-derived oxidants have no role to play in
matrix degradation in the proteolysis assay. Instead the results implicate leukocyte
proteinases as the major arbiters of matrix degradation. The inhibitor profiles of the
C.parvum-elicited leukocytes (>80% neutrophils) and the quartz-elicited leukocytes (50%
neutrophils, 50% macrophages) suggest that their proteolytic activities are similar and
likely to be mediated by serine proteinases. In the quartz population, around 50% of the
population is alveolar macrophages which do not secrete serine proteinases. Some of the
serine proteinase activity may be accounted for by newly recruited monocytes which secrete
serine proteinases and some may be due to membrane associated cathepsin C but further
work is required to clarify this. The finding that leukocytes preincubated on the matrix
were less susceptible to inhibition of their proteinases by al-PI suggests that leukocytes
could retain their proteolytic activity, even in the presence of a sufficiency of
antiproteinase in the alveolar region, due to exclusion of high molecular weight inhibitors
from the site of celkmatrix attachment.
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3.3. The proteolytic activity of human leukocyte populations
The proteolytic activity of peripheral blood neutrophils and alveolar leukocytes,
obtained by bronchoalveolar lavage or by extraction from excised lung tissue, was
compared using a fibronectin matrix.
3.3.1. Dose- and time-response curves of proteolysis by leukocytes from excised
lung tissue
Leukocytes obtained from excised human lung (>95% macrophages) showed dose- and time-
dependent proteolysis of fibronectin (Figure 11).
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Figure 11. Cell number response of fibronectin proteolysis by leukocytes obtained
from resected human lung tissue. Results are the mean(sem) of ft25)]fibronectin
breakdown products released in triplicate wells in a single experiment with
increasing number of cells per well (xlO5).
Release of counts was significantly greater than background at all time points at 1.0x10^
cells/well (p<0.01) but did not reach statistical significance at any other dose, except for
0.1xl0-> cells/well at 4 hours (p<0.005).
3.3.2. Comparison of the proteolytic activity of bronchoalveolar lavage
leukocytes with peripheral blood neutrophils and the response of each
population to exogenous triggers in vitro
Peripheral blood neutrophils were obtained from a healthy volunteer. They were >95%
neutrophils and showed dose-dependent proteolysis of fibronectin after 4 hours which was
significantly greater than background at 0.1 and 1.0x10^ cells/well (p<0.01 and p<0.0005
respectively) (Figure 12).
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The bronchoalveolar leukocytes were obtained from an ex-smoker who had not smoked for
1 year at the time of lavage but who was suspected of having a current chest infection. The
differential count of the bronchoalveolar leukocytes was 86% macrophages, 1%
neutrophils and 13% lymphocytes and the cells were greater than 98% viable as assessed
by trypan blue exclusion. The bronchoalveolar leukocytes had no significant proteolytic
activity even at the maximum concentration of 1.0x10^ cells/well.
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Figure 12. Dose response of fibronectin proteolysis by human bronchoalveolar
lavage leukocytes(HAL) and peripheral blood neutrophils from a differentindividual. Results are the mean(sem) of triplicate wells in a single experiment.
When the assay was performed in the presence of the exogenous trigger, PMA, only the
peripheral blood neutrophils demonstrated increased proteolytic activity (Figure 13).
There was a significant and dose-dependent increase in the proteolytic activity of the




Figure 13. Response of human bronchoalveolar lavage leukocytes (HAL) and
peripheral blood neutrophils to triggering with PMA. Results are the mean(sem) of
triplicate wells in a single experiment.
3.3.3. Summary
Leukocytes obtained from excised lung tissue, at a site distal to a tumour showed dose- and
time-dependent proteolytic activity but those obtained by lavage from the lungs of an ex-
cigarette smoker with a current infection had no such activity; in vitro triggering of the
bronchoalveolar lavage leukocytes with PMA failed to stimulate any increase in their
proteolytic activity. The failure of in vitro stimulation to elicit increased proteolytic
activity of bronchoalveolar leukocytes has been demonstrated several times, with
different cell types in the course of the work for this thesis (3.5.4; 3.6.5). Bronchoalveolar
leukocytes may be refractory to stimulation because of the unique position they occupy in
the body where they are exposed to a continuous insult of exogenous material. Untriggered
peripheral blood neutrophils had intrinsic proteolytic activity but they also responded to
an exogenous stimulatory signal by increased proteolysis of fibronectin. Activation of
peripheral blood neutrophils by the separation procedure cannot be ruled out as a possible
explanation of their intrinsic proteolytic activity. However, their ability to respond to
further triggering in vitro indicates that they were not maximally triggered and suggests
that these cells may exhibit different levels of activation depending on the stimulus. The
responsiveness of peripheral blood neutrophils to in vitro triggers may reflect a requirement
for efficient responses to challenge, at various sites in the body, by these cells. Differences
between the alveolar leukocyte populations in vitro may be related to the methods of
retrieval of the cells. The increased proteolytic activity of the minced lung cells may be
due to the presence of interstitial leukocytes, which are more active than lavage cells, in
the minced lung preparation. Alternatively, the differences between the two lung
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leukocyte preparations may reflect true differences in the activational status of leukocytes
from the bronchoalveolar region in different disease states in vivo.
3.4. Comparative proteolytic activities of resident and
inflammatory bronchoalveolar macrophages and exudate
neutrophils
All of the foregoing results have demonstrated that the numbers of both macrophages and
neutrophils are increased in inflamed lungs. Neutrophils contain considerably more neutral
proteinases than macrophages and although they do not synthesise proteinases once they
have left the bone marrow, they are thought to be a major source of proteinase in inflamed
lungs. Macrophages, however, are capable of enzyme synthesis and may play a part in
increasing the proteinase burden of the lung during chronic inflammation when they are
frequently the predominant cell type. Additionally, macrophage enzymes, being
metalloproteinases are not susceptible to inhibition by al-PI and so are more likely to
remain active in the extracellular fluid of the lung. The relative contribution of each cell
type to connective tissue proteolysis has therefore been investigated by obtaining
bronchoalveolar leukocytes from inflamed lungs and separating them by differential
centrifugation. The proteolytic activity of macrophages from inflamed and control lungs
has been compared with the activity of inflammatory bronchoalveolar neutrophils.
3.4.1. Separation of inflammatory macrophages and neutrophils
Inflammatory leukocytes were obtained by lavage from rat lungs 30 days after
intratracheal injection of lmg of quartz. Total numbers of leukocytes in these animals was
ninefold greater than in the controls and comprised around 50% macrophages and 50%
neutrophils (Table 9). The cells were separated into inflammatory macrophage and
neutrophil populations by differential centrifugation and the total cells and differential
count in the two populations was assessed.
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Table 9. Total cells and differential count in lavage of control or quartz-treated rats and in the
separated quartz populations.
DIFFERENTIAL COUNT (%)
Total cells Mac. Neut. Lymph.*
(x(sd)xlO^)
Control 1.8(0.3) 97 0 3(1)
Quartz 16(2.2) 49(6) 50(13) 1(1)
Quartz macrophages 6.1(2.8) 93(2) 4(2) 3(2)
Quartz neutrophils 8.3(2.7) 16(6) 85(7) 3(1)
* Mac. = macrophages; Neut. = neutrophils; Lymph. = Lymphocytes
Results are presented as the mean(sem)xlO^ of total cells and mean(sem)% of each cell
type in lavage. There were three rats per group in four separate experiments for the control
and whole quartz populations; the cells were pooled in each experiment before preparing
the separated cells, so the data for the quartz macrophages and neutrophils is the
mean(sem) of a single separation in four experiments. The percentage recovery following
the separation procedure was 80-90%.
3.4.2. Proteolytic activity of inflammatory macrophages and neutrophils
The proteolytic activity of the separated, quartz-elicited bronchoalveolar leukocytes and
of control macrophages was assessed in four separate experiments, using the fibronectin
proteolysis assay. Each of the cell populations released significantly more degraded
fibronectin into the supernatant medium than background which was 1628(161) counts per
minute (mean(sem)) (p<0.005) (Figure 14).
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M.C. Cont/MAC Q/MAC Q/PMN
Figure 24. Comparative proteolytic activities of bronchoalveolar leukocytes:-
Cont/MAC=control, QjMAC-macrophages separated from quartz-inflamed
lung, Q/PMN=neutrophils separated from quartz-inflamed lung, MC=medium
control. Results are the presented as counts per minute of degraded fibronectin and
are the mean(sem) of triplicate wells in five separate experiments.
Inflammatory macrophages (4700[387]> and neutrophils (8328[805]) were both significantly
more active than control macrophages- (3250[338J) (p<0.01 and p<0.0005 respectively).
Although the inflammatory macrophages were more active than controls, they were
significantly less active than the inflammatory neutrophils p<0.005). The increased
proteolytic activity of the inflammatory macrophages, compared with controls cannot be
explained by the 4% contamination of neutrophils since that would be expected to increase
the proteolytic activity of the macrophages by only 12%. In effect, the actual increase in
proteolysis over control macrophages was 45%.
3.4.3. Macrophage activation in the peritoneal cavity
In order to substantiate the finding that inflammatory bronchoalveolar macrophages had
enhanced proteolytic activity, intraperitoneal injection of tryptose phosphate broth was
used to produce different populations of inflammatory leukocytes in rats and in mice. Such
treatment elicited no increase in total cells and no change in the differential count in either
species (Table 10) but the proteolytic activity of the inflammatory macrophages was
increased compared with the resident macrophage population.
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Table 10. Total cells and differential count of leukocytes retrieved from the peritoneal cavity 3 days




Mac. Neut. Lymph. Eos.
Control mouse PECS 9.4 83 1 13 3
TP broth mouse PECS 10.8 86 1 11 2
Control rat PECS 6.6 79 1 3 17
TP broth rat PECS 8.0 87 1 0 12
* Mac. = macrophages; Neut. = neutrophils; Lymph. = Lymphocytes; Eos = Eosinophils;
PECS = peritoneal exudate cells; TP broth = tryptose phosphate broth.
Results are based on a single rat or mouse and are expressed as total cells xlO^ and
percentage of each cell type in the peritoneal population.
The proteolytic activity of the tryptose phosphate broth-elicited peritoneal macrophages
was modestly but significantly greater than the resident macrophages for in both rat and
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rigure u. Fibronectin proteolysis by inflammatory macrophages obtained from the
peritoneal cavities of rats and mice injected with tryptose phosphate broth. Cont.
mouse = control mouse macrophages; TP mouse = tryptose phosphate broth-elicited
mouse macrophages; Cont. rat = control rat macrophages; TP rat = tryptose
phosphate broth-elicited rat macrophages. Results are presented as counts per
minute of degraded fibronectin and are the mean(sem) of triplicate wells in a single
experiment.
















The increased proteolytic activity, on a per cell basis, of inflammatory bronchoalveolar
leukocytes from quartz-dosed rats is due largely to the presence of inflammatory
neutrophils which are at least twice as active as resident or inflammatory macrophages in
causing fibronectin degradation. However, macrophages can also be activated to secrete
increased proteinase in response to an in vivo signal. The increased activity of the
inflammatory macrophages, together with the markedly increased cell numbers in lavage
may make a substantial contribution to the proteinase burden in the inflamed lung
parenchyma.
3.5. The magnitude and duration of the inflammatory response to
particles deposited in the lung by intratracheal instillation
The initial inflammogenic potential of particles depositing in the lung is only one
determinant of their potential to inflict damage on the lung tissue and other factors are
likely also to contribute to that harm. In particular, the biodegradeability of particles is
probably of major importance in this respect. Therefore, in this section of the work, the
initial inflammogenicity and durability of particles has been related to the duration of
the tissue response which they evoke in the lung. The potential role of these two
parameters in lung damage was assessed by measuring the magnitude and duration of the
lungs' response to particles of different durability and pathogenic potential, administered
by intratracheal instillation. This exposure method is preferable in this type of study,
since it allows a direct comparison of particles and can be manipulated to give information
on the effects of particle size, number, surface area or mass. In this study the comparisons
were based on the mass of particles administered. A comparison has been made between
the alveolitis elicited by two different biodegradable (and hence non-durable) particles
and that evoked by the non-toxic, durable mineral dust, TiC>2 and the harmful, durable
mineral dust, DQl2 quartz.
3.5.1. Total number of leukocytes retrieved by bronchoalveolar lavage
All of the particles provoked a transient increase in the number of leukocytes in the
bronchoalveolar lavage one day after injection (Figure 16), which was most with C.
parvum (26.7[l](mean[sd])xl0^) and least with TiC>2 (11.4[1.7]); the total number of
leukocytes in the bronchoalveolar lavage in each treatment group was significantly
greater than in the pooled controls (4.3[0.7]) at this time point (pcO.OOl). (The pooled
control data was obtained by taking the mean of the control data for all time points).
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Time (days) following exposure
Figure 16. Total cells in bronchoalveolar lavage with time following intratracheal
injection of the indicated particles. Results are the mean(sem) of three rats per group
at each time point.
With the exception of quartz, the alveolitis declined rapidly, approaching background
levels by 3 days in the TiC>2-treated animals (6.3[0.6]) and 30 days in the zymosan-treated
animals (7.7[1.2]). Leukocyte numbers also approached background levels by 30 days in
those animals treated with C.parvum (11.9[2.1])(mean[sd] % neutrophils in lavage). The
response to quartz, however, though similar in magnitude to the zymosan response at 1 day
(17.3[0.9] and 17.0[1.0] respectively), showed only a slight decrease at 3 days; thereafter,
the number of leukocytes in the quartz bronchoalveolar lavage escalated and, by 30 days
was 10-fold greater (51.0[8.3]) than in the pooled controls (4.3[0.7]).
3.5.2. Percentage of neutrophils in bronchoalveolar lavage of control and treated
rats
The percentage of neutrophils in the bronchoalveolar lavage reflected a typical acute
inflammatory response (Figure 17) for most of the particles, with a peak of neutrophil
recruitment 1 day after the intratracheal injection; there were significantly more




















Time (days) following exposure
Figure 17. Percentage of neutrophils in lavage fluid with time following
intratracheal injection of the indicated particles. Results are the mean(sem) of three
rats per group at each time point.
The least influx of neutrophils was seen in the Ti02-treated rats (48[7])(mean[sd]%) and
the greatest, in those dosed with C.parvum (82[3]). The percentage of neutrophils in the
bronchoalveolar lavage leukocytes subsided rapidly, returning to around background levels
(0) within 5 days for TiC>2 (1[0.1]) and zymosan (2.6[0.3]) and 15 days for C.parvum (0). In
the quartz-dosed animals, however, although the percentage of neutrophils decreased
from a peak of 64(2.4) at 1 day to 32(2.1) at 3 days, it then persisted at around 30% for the
remaining 27 days of the experiment.
3.5.3. Fibronectin-degrading activity of bronchoalveolar leukocytes
The proteolytic activity of the bronchoalveolar leukocytes reflected the cellular response
(Figure 18), being significantly greater than the controls at 1 day with all of the
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Figure 18. Proteolytic activity of the indicated inflammatory leukocytes with time
following intratracheal injection of particles. Results are expressed as counts per
minute of degraded fibronectin released into the culture medium/lxlO5 cells and are
the mean(sem) of three wells per sample and three animals per treatment group at
each time point.
The quartz-elicited leukocytes had 6-fold greater activity than the controls at 1 day and
this was still 5-fold greater than the controls at 30 days, when all the other populations
had returned to control levels.
The proteolysis assay measures the proteolytic activity per cell but an additional factor
influencing the overall protease burden in the lung is the total number of inflammatory
leukocytes present. Accordingly, the proteolysis data per cell was multiplied by the total
number of leukocytes in the bronchoalveolar lavage (Figure 19) to gain an indication of the
potential total protease burden in the bronchoalveolar region in arbitrary units.
Time (days) following exposure
Figure 19. Proteolytic activity per cell multiplied by total number of cells in the
bronchoalveolar lavage to give an indication of the potential overall proteolytic
burden in arbitrary units in the alveolar region. Results are the mean of three rats
per treatment group at each time point.
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This data showed that 1 day after treatment, the C.parvum rats had the greatest overall
potential for proteolytic injury in the lung; the total proteinase burden in these animals
was 31 times that of the controls. However, this was rapidly superceded by the proteinase
levels in the quartz-treated animals where, by 30 days after treatment, the total
proteinase burden in the alveolar region was 72 times that of the controls. So, the potential
for proteolytic injury in the lungs of the quartz-treated rats was considerably greater than
in any other treatment group with respect to the increased proteolytic activity per
leukocyte, the total number of leukocytes and the duration of the alveolitis.
3.5.4. In vitro stimulation of the proteolytic activity of bronchoalveolar
leukocytes
None of the bronchoalveolar leukocyte populations, harvested 5 days after exposure in
vivo, showed any increased proteolysis of fibronectin when the assay was performed in the
presence of TiC>2, quartz or zymosan particles or PMA (Table 11).
Table 11. Effect of in vitro triggering, over a four hour period, on fibronectin proteolysis by
bronchoalveolar leukocytes in vitro, (see test for explanation)
IN VIVO TREATMENT
0 Ti02 quartz zymosan PMA
Mean 109 112 106 111 109
SD 19 22 12 20 12
The triggers used were 0, TiC>2, quartz, zymosan and PMA. Results are presented as
percentage of medium control obtained in 1-3 separate experiments (3 wells/sample). Since
no differences were obtained with any of the triggers, all of the data (both with and
without triggers) has been pooled to derive the means as shown. The incubation time of
the assay, however, is only 4 hours which might have been too short for the stimulatory
effect of the particles to become apparent. The bronchoalveolar leukocytes were therefore
cultured for three days in vitro, in the presence of particles, before proteolytic activity
(measured as fibronectin degradation) in the culture supernatants was assessed. These
experiments also showed no increased proteolytic activity in response to in vitro triggering
(Table 12).
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Table 12. The effect of in vitro triggering over a 3 day period on the proteolytic activity of
supernatants from control leukocytes and those obtained 5 days after intratracheal injection of
particles, (see text for explanation)
IN VIVO TREATMENT (5 DAYS)
0 TiC>2 quartz zymosan
mean 91 104 140 153
SD 10 3 13 6
Results are presented as percentage of control supernatant activity and are the mean of 1-3
separate experiments with 3 wells per treatment group. The in vitro triggers used were
TiC>2, quartz, zymosan and PMA. Since the triggers had no effect, all of the data (both
with and without triggers) for each leukocyte population was pooled to give an indication
of overall differences in the proteolytic activity of different leukocyte supernatants.
Although in vitro triggering did not enhance the proteolytic activity of inflammatory
leukocyte supernatants, they had greater baseline activity than controls
3.5.5. Summary
The foregoing results indicate that different particles have varying potentials to elicit
leukocyte recruitment when they first deposit in the lung. The persistence of the tissue
response varies with the type of particle and is related both to the durability of the
particles and to their ability to retain inflammogenic activity in the lung. Inflammatory
bronchoalveolar leukocytes have enhanced proteolytic activity compared with resident
alveolar leukocytes. Activation of the leukocytes is not mediated solely by exposure to
particles in vitro but is dependent on in vivo exposure.
3.6. Bronchoalveolar leukocyte response in rats inhaling coalmine
dust
Having established that the inflammatory response to intratracheal injection of particles
was a sensitive indicator of the comparative harmfulness of particles gaining access to the
lung, the next question addressed was how the alveolitis would develop in response to
particles deposited in the lung by the more realistic inhalation mode, where the
accumulation of a particle burden is more gradual than with intratracheal exposure.
In light of the progressive nature of pneumoconiosis, a further facet of this part of the
study was to investigate the persistence of the alveolitis following cessation of dust
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exposure. The cellular source of the proteinase activity was also investigated by assessing
the inhibitor profile of the leukocytes. Previous experiments had indicated that, in vitro,
the particles themselves did not alter the proteolytic activity of leukocytes (3.5). The
effect of other triggers of leukocyte activation were therefore assessed, in order to
determine whether exposure to coalmine dust would potentiate the response of leukocytes
to additional stimuli which might be present in the inflammatory milieu of the lung.
3.6.1. Total number of leukocytes retrieved by bronchoalveolar lavage
The total number of leukocytes in the bronchoalveolar lavage increased with duration of
dust inhalation (Figure 20); following 52 days of exposure there were significantly more
(13.2[0.9]) (mean[sem])xlO^ leukocytes in the bronchoalveolar lavage of treated rats than
in the controls (4.3[0.8]) (pcO.OOl).
Duration of dust exposure (days) 64 days recovery
Figure 20. Total leukocytes in bronchoalveolar lavage fluid ivith time of dust
exposure. Results are the mean(sem) of 4 dust-exposed and two control rats at each
time point during dust-exposure and following 32 days dust-exposure and 64 days
"recovery "
In those animals which were exposed to coalmine dust for 32 days followed by a period of
64 days breathing room air (recovery animals), the total number of leukocytes in the
bronchoalveolar lavage returned to control levels.
3.6.2. Percentage of neutrophils in the bronchoalveolar lavage
There were no neutrophils in the bronchoalveolar lavage of control animals but increasing
numbers were present in the treated animals as the duration of exposure increased (Figure
21); the increase was statistically significant at all time points (pcO.OOl).
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Although the total number of leukocytes in the bronchoalveolar lavage of the recovery
animals was similar to that of the controls (Figure 20), the percentage of neutrophils
remained elevated. This is indicative that some degree of inflammation persisted long
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64 days recovery
Figure 21. Percentage of neutrophils in lavage with duration of dust exposure.
Results are the mean(sem) of 4 dust-exposed and 2 control rats at each time point
and following 32 days dust-exposure and 64 days "recovery"
3.6.3. Proteolysis of fibronectin by coalmine dust-elicited bronchoalveolar
leukocytes
The proteolytic activity of coalmine dust-elicited leukocytes increased rapidly to a level
which was significantly greater than control cells at all time points, including after 64
days recovery (p<0.001) (Figure 22) but it did not increase with duration of dust exposure.
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Figure 22. Activity of bronchoalveolar leukocytes in degrading fibronectin with
duration of dust exposure, expressed as counts per minute of degraded fibronectin
released into the supernatant medium/lxHfi cells and are the mean(sem) of three
wells per treatment group. Results are the mean(sem) of 4 dust-exposed and 2
control rats at each time point and following 32 days dust-exposure and 64 days
"recovery"
The proteolytic activity of the bronchoalveolar leukocytes, averaged over all time points
was 2983(562) (mean[sem])cpm for the dust-elicited cells and 1448(313) for the controls. To
obtain an approximation of the potential protease burden in the alveolar region, the
figures for total leukocytes in lavage and proteolytic activity per cell were multiplied
(Figure 23).
Figure 23. Proteolytic activity per cell multiplied by the total number of leukocytes in
lavage and plotted against duration of dust exposure to estimate the potential burden
of proteolytic activity in the alveolar region of the lung in arbitrary units. Results are
the mean(sem) of 4 dust-exposed rats and 2 controls at each time point and
following 32 days dust-exposure and 64 days "recovery
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The total potential protease burden in the lung in arbitrary units, was 6-fold greater in the
coalmine dust-exposed animals than in the controls at day 52 of exposure and still about
double that of the controls in the recovery animals. These results also reflect ongoing
inflammation in the alveolar region, long after the cessation of dust exposure.
3.6.4. Inhibitor profile of the proteolytic activity of coalmine dust-elicited
bronchoalveolar leukocytes
To further investigate the cellular source of the increased proteinase activity, the
proteolytic activity of the bronchoalveolar leukocytes 8 days after the start of dust-
exposure was tested in the presence of inhibitors of serine proteinases (neutrophil) and
metalloproteinases (macrophage) which were added into the assay together with the
leukocytes. The inhibitors used were al-PI, a2M, foetal calf serum and EDTA. Of these,
only al-PI is specific for serine proteinases whilst EDTA is specific for metalloproteinases;
a2M and foetal calf serum inhibit both types of proteinase. Each inhibitor caused a dose-
dependant inhibition of proteolysis (Figure 24) which was significant at 0.01, 0.1 and 1.0
mg/ml for al-PI (p<0.001), at 0.5 mg/ml for a2M (p<0.005),at 1,5 and 10% serum (p<0.005)






















Figure 24. Inhibition of activity in the fibronectin proteolysis assay, of
bronchoalveolar leukocytes from control rats or rats exposed to coalmine dust for 8
days. The inhibitor concentrations used were al-PI and EDTA- 0.01, 0.1 and
lmg/ml, a2M- 0.005, 0.05 and 0.5mg/ml and serum- 1, 5 and 10%. Results are
expressed as counts per minute of degraded fibronectin released into the supernatant
medium and are the mean(sem) of three wells for each inhibitor concentration.
Previous experiments using exogenous enzymes (3.1.1.2.) indicated that EDTA and al-PI
could distinguish serine and metalloproteinases and should therefore distinguish
macrophage from neutrophil proteinase activity. With the coalmine dust-elicited
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leukocytes, al-PI was a highly efficient inhibitor of the proteolytic activity of the
leukocytes but EDTA had very little effect. The results suggest, therefore, that the
proteolytic activity of the leukocytes was largely mediated by serine proteinase and hence
was neutrophil-derived.
3.6.5. In vitro stimulation of the proteolytic activity of bronchoalveolar
leukocytes
As previously demonstrated for other bronchoalveolar leukocyte populations (3.3, 3.5.1),
neither the control nor the coalmine dust-elicited inflammatory leukocytes were
stimulated by triggering in vitro; PMA and zymosan failed to elicit enhanced proteolysis of
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Figure 25. Triggering of the proteolytic activity of 8 day dust-elicited
bronchoalveolar leukocytes and control cells by zymosan at 1, 10 and 100ng/ml and
PMA at 0.1,1.0 and 10 pg/ml. Results are expressed as counts per minute of
degraded fibronectin released into the supernatant medium and are the mean(sem)
of triplicate wells per concentration of trigger.
The failure of the coalmine-dust-elicited leukocytes to respond to further triggering in vitro
may have been because they were already maximally stimulated in vivo; their proteolytic
activity reached its maximum within 8 days from the start of dust exposure and remained
constant thereafter. However, the evidence with other bronchoalveolar leukocyte
populations suggests that leukocytes from the bronchoalveolar region of the rat are
generally refractory to in vitro stimulation from a single stimulus at least.
3.6.6. Summary
Inhalation of coalmine dust, at plausible levels in relation to the industrial situation,
evoked the gradual development of an alveolitis which increased with duration of
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exposure. The inflammatory leukocytes had greater proteolytic activity than control
leukocytes but an early increase in proteinase activity remained constant and was not time-
dependent. The inhibitor profile of the inflammatory leukocytes at the 8 day time point
suggested that their proteolytic activity was largely mediated by serine and hence
neutrophil proteinases. Neither controls nor inflammatory leukocytes obtained following 8
days of dust exposure responded to in vitro triggering with PMA or zymosan which
indicates, as before (3.3) that multiple in vivo stimuli are probably essential for leukocyte
activation to take place.
3.7. Modulation of quartz-induced alveolitis by aluminium lactate
The fibrogenic potential of mixed dusts containing quartz is often less than predicted on the
basis of the proportion of quartz in the dust. In mixed dusts whose fibrogenicity is less than
would be predicted by the quartz content, it is possible that surface modification of the
quartz particles by soluble compounds released by the non-quartz component(s) has
rendered them less harmful. Minerals such as mica and smectite are present in some mixed
dusts such as coalmine dust and can release aluminium compounds which may coat the
quartz particles and so render them less toxic. This situation has been modelled in vitro by
(a) precoating quartz particles with an aluminium compound and then comparing their
inflammogenic potential with that of untreated quartz particles and (b) exposing rats to
quartz and then administering aluminium lactate into the lung one month later and
assessing the progression of the alveolitis.
3.7.1. Total leukocytes in the bronchoalveolar lavage
Intratracheal instillation of quartz evoked a marked and persistent alveolitis which was
sustained up to 12 weeks after dosing (Figure 26); >90% of the bronchoalveolar leukocytes
were viable.
Total leukocytes in lavage of the quartz-treated animals was significantly greater than
controls at all time points (p<0.001). In animals dosed with quartz/aluminium lactate,
there was a small increase in the number of leukocytes lavaged one week after treatment
(8.6 [2.0] (mean[sem]) x 10^) but this was not significantly greater than in the control
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Figure 26. Total bronchoalveolar leukocytes in lavage with time following
intratracheal injection of quartz or quartz pretreated with aluminium lactate.
Q/Al. Lact.= quartz pretreated with aluminium lactate. Results are the mean(sem)
of three rats per group in two separate experiments.
3.7.2. Percentage of neutrophils in the bronchoalveolar lavage
The percentage of neutrophils rapidly increased in the animals dosed with native quartz
and remained at around 50% for up to 12 weeks (Figure 27).
Time (weeks) following exposure
Figure 27. Percentage of neutrophils in the bronchoalveolar leukocyte population
with time following intratracheal injection of quartz or quartz pretreated with
aluminium lactate (Q/Al. Lact.). Results are the mean(sem) of three rats per
treatment group in two separate experiments.
The inflammation was also sustained in the quartz/aluminium lactate-dosed animals.
Although the percentage of neutrophils was less than in those treated with native quartz,
there remained significantly more neutrophils than in the control animals up to 12 weeks
after injection.
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3.7.3. Proteolytic activity of the bronchoalveolar leukocytes
Bronchoalveolar leukocytes from quartz-dosed animals had greater ability to degrade
fibronectin than control leukocytes (significant at 1 and 4 weeks, pcO.OOl, p<0.005
respectively) or those obtained from rats dosed with quartz/aluminium lactate
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Figure 28. Fibronectin degrading activity of control bronchoalveolar leukocytes or
those from rats exposed to quartz or quartz/aluminium lactate (Q/Al. Lact.)
Results are expressed as counts per minute of degraded fibronectin released into the
supernatant medium and are the mean(sem) of triplicate wells for three rats per
treatment group in two separate experiments.
The latter were also more active than control leukocytes (significant at 4 weeks, p<0.005).
The proteolytic activity of both the quartz-treated and the quartz/aluminium lactate-
treated animals was maximal one week after treatment and declined linearly thereafter.
The proteolytic activity per cell of the leukocytes was multiplied by the total number of
leukocytes in the lavage to assess the potential proteinase burden in the lungs (Figure 29).
Although the activity per cell of the quartz-elicited leukocytes was less than double that
of those elicited by quartz/aluminium lactate, the potential proteinase burden in the
alveolar region was markedly different. In the former, there was a 13-fold increase over
the controls at 12 weeks but in the latter, the increase was only 4-fold, so the proteolytic
threat to the lungs was markedly reduced by precoating the quartz particles.
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Time (weeks) following exposure
Figure 29. A measure of the potential proteinase burden of the whole lung in control
rats and rats exposed to quartz or quartz/aluminium lactateiQ/Al. Lact.). Overall
proteinase Burden calculated in arbitrary units as total cell number in the
bronchoalveolar lavage x proteolytic activity per cell. Results are the mean(sem) of
triplicate wells per sample and three rats per treatment group in two separate
experiments.
3.7.4. Delayed treatment with aluminium lactate
3.7.4.1 Total leukocytes in the lavage
In terms of the total number of leukocytes in the lavage, animals dosed with aluminium
lactate 1 month after quartz exposure showed no reduction in alveolitis by one week after


















Figure 30. Effect of delayed treatment with aluminium lactate on the total number
of leukocytes in bronchoalveolar lavage: 50pg aluminium lactate was injected
intratracheally, 1 month following intratracheal injection of lmg quartz and the
lavage cell numbers were estimated 1 week or 1 month thereafter. Results are the
mean(sem) of three rats per treatment group in two separate experiments.
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There were 9.7(0.7) x 10^ (mean[sem]) leukocytes in the quartz-treated animals and 9.4(1.2)
in the quartz/aluminium-lactate-treated animals. By one month after aluminium lactate
treatment, however, the total number of bronchoalveolar leukocytes had increased in both
groups but there were significantly fewer leukocytes in aluminium-treated rats- 15.3(2.2)
than in the untreated quartz animals- 28.0(7.8), (p<0.001). This suggests that aluminium
treatment of quartz-exposed lung suppressed leukocyte recruitment.
3.7.4.2. Percentage of neutrophils in the lavage
Delayed aluminium lactate treatment also had an effect on the percentage of neutrophils
in lavage (Figure 31).
1 week 1 month
Figure 31. Effect of delayed treatment with aluminium lactate on the percentage of
neutrophils in bronchoalveolar leukocytes from rats exposed to quartz for 1 month,
followed by aluminium lactate for a further 1 week or 1 month. Results are the
mean(sem) of three rats per group in two separate experiments.
One week after aluminium treatment there were fewer neutrophils in the lavage 38 (2.9)%
(meanfsem]) than in the untreated quartz-dosed animals-46 (3.2) but the difference was not
statistically significant. By one month after aluminium treatment, however, there was a
significant reduction in the percentage of neutrophils in lavage 19(3.6) compared with the
quartz animals 40.5(3.4) (p<0.0025).
3.7.4.3. The effect of delayed aluminium lactate in reducing macrophage and
neutrophil recruitment to the bronchoalveolar region of the lungs.
The reduced influx of leukocytes, 4 weeks after aluminium lactate treatment could have
been due to suppression of either or both macrophage and neutrophil recruitment. The
absolute number of macrophages and neutrophils in lavage at 1 and 4 weeks were therefore
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calculated from the data of total cells and percentage of neutrophils in lavage (Table 13).
The percentage increase of each cell type was then calculated and revealed that
recruitment of macrophages and neutrophils were both suppressed, neutrophils marginally
more so than macrophages.
Table 13. Reduction of macrophage and neutrophil recruitment by aluminium lactate treatment
of rats exposed to quartz.
TREATMENT GROUPS
Total neutrophils Total macrophages
Weeks Q QA Q QA
1 4.5 3.6 5.8 5.2
4 1_L2 55 165 95
% increase 267 161 290 183
Q= animals treated with quartz alone. QA= animals treated with quartz followed by
aluminium lactate.
Results are presented as total cells of each type x 10^ and % increase in total cells between
1 and 4 weeks.
3.7.4.4. Proteolytic activity of bronchoalveolar leukocytes following delayed
treatment with aluminium lactate
Delayed aluminium lactate treatment of rats exposed to quartz had no effect on the
proteolytic activity of the bronchoalveolar leukocytes either 1 week or 1 month after the
aluminium lactate treatment (Table 14). Leukocytes from quartz-exposed and quartz /
aluminium lactate-exposed rats were similar in their ability to degrade fibronectin and
were significantly more active in this respect than control leukocytes (p<0.005).
Table 14 Effect of delayed aluminium lactate treatment on the proteolytic activity of quartz-
elicited bronchoalveolar leukocytes
FIBRONECTIN DEGRADATION
1 week 1 month
CONTROL 431(34) 531(169)
QUARTZ ALONE 2072(59) 2510(591)
QUARTZ/ALUMINIUM LACTATE 2595(76) 2316(613)
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Results are expressed as mean(SEM) counts per minute of degraded[125I] fibronectin
released for triplicate samples and two experiments at each time point.
3.7.5. Effect of aluminium lactate treatment on the inflammatory response to C.
parvum
In order to ensure that the effect of delayed aluminium lactate treatment was specific for
the quartz particles and not a generalised effect in inhibiting leukocyte responses, an
alternative inflammogenic particle (C.parvum) was administered to the lungs and the
effect of delayed aluminium lactate treatment on the inflammatory response to those
particles was assessed. Lungs of animals dosed with C. parvum alone or C.parvum and
concomitantly administered aluminium lactate were equally effective in mounting an
inflammatory response (Table 15). Aluminium lactate had no effect on total leukocytes or
percentage of neutrophils in the bronchoalveolar lavage and the proteolytic activity of
the bronchoalveolar leukocytes also remained unaltered. This indicated that the effect of
aluminium was indeed specific for quartz.
Table 15 Effect of aluminium lactate on the inflammatory response elicited by intratracheally
instilled C.parvum.
Days following intratracheal injection
1 3 15
Cp. Cp/Al. Cp. Cp/Al. Cp. Cp/Al.
X 21.9 21.2 13.4 22.6 11.1 13.0
sd 2.6 2.1 3.0 0.6 1.8 2.9
X 76 82 34 37 0.3 0.3
sd 3.5 0.3 4.1 7.6 0.3 0.3
5.0 4.8 3.5 3.2 1.3 1.3
% PMN
Proteolysis ratio
Cp=C.parvum; Cp/Al=C.parvum administered concomitantly with aluminium lactate.
Results represent the mean (SEM) for triplicate samples at each time point, except where
the proteolytic activity is expressed as released counts as a ratio of background.
3.7.6. The tissue response to quartz and to quartz/aluminium lactate
One week after quartz or quartz/aluminium lactate treatment there was little evidence of
tissue damage but occasional macrophage accumulations were present at bifurcations of
alveolar ducts. By 1 month after quartz treatment, areas of alveolar lipoproteinosis were
seen in conjunction with septal hyperplasia; these areas were minimal in animals treated
with quartz/aluminium lactate. After 3 months, the tissue injury had progressed in both
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treatment groups with the greatest damage apparent in the quartz-treated animals
(Figure 32).
Rats treated with quartz/aluminium lactate showed marked areas of tissue injury but
these were less severe than in animals dosed with quartz alone and comprised only about
5% of the entire tissue, compared with around 80% in the quartz-treated animals. Late
dosing with aluminium lactate had no effect in reducing the tissue response to quartz.
Figure 32. Tissue response 3 months after intratracheal injection of (a) lmg quartz
pretreated with aluminium lactate or (b) native quartz. (x500 magnification).
Areas of hyperplasia (arrowed) were more extensive in lungs treated with quartz
alone than in those treated with Q/Al.Lact. Lipoproteinosis (indicated by X in 8a
was also seen extensively in quartz-treated lungs but does not show up in figure 8b.
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3.7.7. Summary
The activity of quartz in biological systems has been related to its surface reactivity. This
section of the thesis has addressed the role of quartz surface reactivity in mediating the
inflammogenic potential of quartz. Aluminium is known to react with the surface of quartz
particles and in this series of experiments a soluble aluminium compound, aluminium
lactate reduced all of the measured parameters of the inflammatory response to quartz in
rat lungs. This was true whether the aluminium was reacted with the quartz prior to- or
administered after quartz injection. The aluminium acted on the quartz particles and not on
the bronchoalveolar leukocytes as shown by its failure to reduce the inflammatory
response to C.parvum. These results may go some way to explain the unexpectedly low






Alveolitis is a characteristic feature of the pneumoconioses (Voisin et al, 1985; Begin et al,
1986) and leukocyte neutral proteinases, which are elevated in the bronchoalveolar
lavage of pneumoconiotic patients (Hayem et al, 1980; Sablonniere et al, 1983), have been
implicated in the pathogenesis of these diseases. Many previous experimental studies
have demonstrated the development of alveolitis in animals exposed to mineral dusts (see
1.10). In one of those studies (Sykes et al, 1983), levels of elastase in the bronchoalveolar
lavage fluid were measured and were found to be increased in silica-exposed animals.
Silica exposure in vitro has also been shown to cause increased elastase release by alveolar
macrophages (Gulyas et al, 1988). However, there has been no systematic study of the role
of leukocyte proteinases in the pathogenesis of pneumoconiosis. The aim of the work
presented in this thesis was therefore, to assess the development of alveolitis in rats
exposed to mineral dusts and to measure the proteolytic activity of the inflammatory
leukocytes. The specific aims were to develop a proteolysis assay which would
effectively assess the proteolytic activity of bronchoalveolar leukocytes and then, using
that assay, to measure the activity of leukocytes at various stages of the inflammation
elicited in rat lungs by deposition of different types of dust particle.
4.1. The proteolysis assay
4.1.1. Leukocyte proteinases
Much of the work investigating the proteolytic potential of bronchoalveolar leukocytes
has been accomplished by measuring the secretion of specific proteinases by alveolar
macrophages (White et al, 1981b; Hibbs et al, 1987) and peripheral blood neutrophils
(Janoff et al, 1979; Henson and Johnston, 1987). The content of individual proteinases in
lysed peripheral blood neutrophils (Baugh and Travis, 1976; Gardi and Lungarelli, 1986),
neutrophils from purulent sputum (Twumasi and Liener, 1972), alveolar macrophages
(Levine et al, 1976) and peripheral blood monocytes (Senior et al, 1982) has also been
assessed. However, inflammatory leukocytes secrete an array of proteinases and
measuring secretion of only one of those proteinases is likely to lead to an underestimation,
or in some cases (Levine et al, 1976), an overestimation of the true proteolytic potential of
the leukocytes. In this study, therefore, a solid phase assay measuring proteolysis of
connective tissue components was used to measure the overall proteolytic activity of viable
bronchoalveolar leukocytes, and hence to predict their potential to inflict proteolytic
damage on the delicate tissues of the alveolar septum.
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4.1.2. Fibronectin degradation as a measure of proteinase
The assay used was first described by Johnston and Varani (1981) and was subsequently
modified by Campbell et al (1982) for estimating the proteolytic potential of peripheral
blood neutrophils using [1^1] fibronectin as substrate. In the lung, leukocytes are in close
contact with the connective tissue of the extracellular matrix; the solid phase proteolysis
assay technique, where the leukocytes are cultured on a matrix of connective tissue
molecules, reflects this situation as closely as is possible in vitro. In the present study, the
proteolysis assay was developed using radio-iodinated connective tissue molecules
(fibronectin, laminin and denatured collagen types I and IV) and tested using exogenous
proteinases. All of the connective tissue molecules labelled with high specific activity
and consistently formed uniform matrices in microtitre plates. All of the matrix
components were readily degraded by the proteinases, thus confirming the suitability of
the assay for measuring the ability of leukocyte proteinases to digest alveolar connective
tissue. Further work to standardise the assay was carried out using the [^^1]fibronectin
matrix and this established that the assay was capable of detecting, in a dose- dependent
manner, the activity of a variety of neutral proteinases. Different classes of proteinase
could be discriminated on the basis of their inhibition by specific proteinase inhibitors;
the exogenous proteinases collagenase (metalloproteinase), and elastase (serine
proteinase), were inhibitable in the assay by EDTA (metalloproteinase inhibitor) and by
al-PI (serine proteinase inhibitor) respectively. The [^^1]fibronectin proteolysis assay
developed for this thesis can thus be seen to be a relevant, sensitive and useful assay of
leukocyte proteinase.
4.2. The experimental models
4.2.1. Pathogenic effects of silica and coalmine dust in rat lungs
Deposition of silica or coalmine dust in the human lung results in the formation of areas of
nodular and interstitial fibrosis, emphysema and, particularly in the case of silica, type II
cell hyperplasia and alveolar lipoproteinosis (Morgan and Sea ton, 1984). The lesions
which arise following silica deposition in rats are similar to those in man: the rat model
shows the development of fibrotic lesions and alveolar lipoproteinosis in the lung
parenchyma (Martin et al, 1977; Reiser et al, 1983) and also gives rise to emphysema
(Wright et al, 1988). Inhalation of coalmine dust in rats leads to the development of
typical pneumoconiotic lesions (Robertson et al, 1988). The foregoing studies confirm that
the rat is a suitable model for the study of the pathogenesis of pneumoconiosis in man.
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4.2.2. Exposure techniques
In the present study, two different methods of particulate-exposure were used to elicit
inflammatory bronchoalveolar leukocytes:- intratracheal instillation and inhalation.
Each technique has its own inherent advantages and disadvantages and so the most
appropriate exposure method was chosen in each part of the study according to the
research question being asked. The advantages of inhalation exposure are that it is a more
realistic mode of exposure than intratracheal instillation and the particles are more
homogeneously distributed throughout the lung (Brain et al, 1976). The accumulation of
particles inhaled into the lung is influenced by many factors, in particular their airborne
mass concentration and mass median aerodynamic diameter (MMAD). The airborne mass
concentration of dust used in the inhalation experiments was 10 mg/m^ of respirable dust,
(ie dust with a MMAD of 3-5 microns). This dust concentration is near the maximum
permissible level in British collieries which is 7mg/m^ measured in the return roadway of
the pit face. The exposure regimen used in this series of experiments was, therefore,
plausible for a workplace exposure. The two major disadvantages of inhalation exposure
are that it is expensive and time consuming to run the inhalation chambers for long enough
to build up a substantial deposited mass of dust in the lung. Also, differences in deposition
and clearance patterns of different particles preclude the use of this technique for direct
comparison of the intrinsic inflammogenic properties of the particles. Intratracheal
instillation of particles was frequently used in this study, partly as a means of obtaining
large numbers of inflammatory leukocytes quickly without the expense of running exposure
chambers. It was also used to directly compare the inflammogenicity of particles. The
major disadvantage of intratracheal injection is that all of the particles are deposited in
the deep lung where some of them would not normally deposit with inhalation exposure.
However, the consistent deposition of a known mass of particles using the intratracheal
technique, is of distinct benefit when comparing the intrinsic inflammogenic properties of
different types of particle. In this study, therefore, intratracheal instillation was used to
compare the magnitude and persistence of the inflammatory bronchoalveolar leukocyte
response elicited by a variety of particles.
4.3. Assessment of the proteolytic activity of bronchoalveolar
leukocytes
4.3.1. Proteolysis of laminin and denatured collagen types I and IV and dose and
time-responses of fibronectin proteolysis
Preliminary work in measuring the proteolytic activity of bronchoalveolar leukocytes was
carried out using resident alveolar macrophages and two inflammatory bronchoalveolar
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leukocyte populations of varying macrophage and neutrophil content, to establish
optimum conditions for the assay. The proteolytic activity of the bronchoalveolar
leukocytes was both dose- and time-dependent and was inhibitable by antiproteinases but
not antioxidants. This reinforced our earlier finding that oxidants do not play a major part
in tissue injury in inflamed lung (Donaldson et al, 1988d) but is contrary to previous
suggestions that leukocyte oxidants might contribute to matrix damage in inflamed lung
(Riley and Kerr, 1985). These results confirmed that the assay could detect differences in
the proteolytic activity of different bronchoalveolar leukocyte populations and
established that matrix degradation by the leukocytes was proteinase-mediated as
previously described (Chapman and Stone, 1984; Sibille et al, 1986). Each of the
bronchoalveolar leukocyte populations degraded denatured type I and type IV collagen,
fibronectin and laminin. Thus, both resident and exudate bronchoalveolar leukocytes have
proteolytic activity which is capable of damaging several of the connective tissue
molecules present in the alveolar septum. The low proteolytic activity of resident alveolar
macrophages, found in this study, may be an artifact caused by limited activation of the
cells during culture on the fibronectin matrix (Kuriowa et al, 1988). This level of activity
has also been reported in bronchoalveolar lavage cells from healthy human volunteers
(Chapman and Stone, 1984). However, the in vitro activity may actually reflect
macrophage activity in vivo. This activity may be an indication of a potential proteinase
burden in the alveolar region which can be effectively limited by the normal
antiproteinase screen, so preventing connective tissue damage. The increased activity of
the inflammatory leukocytes in this rat model of lung inflammation supports the current
view (see 1.7.) that inflammatory leukocyte proteinases play a major part in the tissue
damage associated with chronic lung inflammation.
4.3.2. Relationship between neutrophil content and proteolytic activity
Neutrophil proteinases have frequently been cited as being central to connective tissue
proteolysis in inflamed lung (Spitznagel et al, 1980; Gadek et al, 1984; Janoff, 1985) because
neutrophils, constitutively, contain considerably more neutral proteinase than
macrophages (Janoff et al, 1979; Gadek et al, 1984). In the preliminary experiments in this
study, therefore, the role of neutrophils in connective tissue proteolysis was addressed by
measuring the proteolytic activity of bronchoalveolar leukocytes of varying neutrophil
content. C.parvum leukocytes contained most neutrophils and were the most active, quartz
leukocytes contained fewer neutrophils and were less active than the C.paruum-leukocytes
but were more active than the resident macrophages (no neutrophils). Although there was
a relationship between proteolytic activity and the proportion of neutrophils in each
population, the correlation was not perfect with more proteolytic activity in the
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inflammatory populations than would be predicted by their neutrophil content. This
suggests that 1) inflammatory macrophages might also contribute to the increased
proteolytic activity of the quartz leukocytes, or 2) neutrophils in an inflammatory
population containing a high proportion of macrophages, had greater proteolytic activity
than those in populations containing minimal numbers of macrophages. Further
experiments were therefore carried out to compare the proteolytic activity of
inflammatory macrophages with that of exudate neutrophils and resident macrophages;
these are discussed later in this chapter (4.9).
4.33. Proteolytic activity of C.parvum-elicited cell supernatants, lysed cells and
intact, viable cells
In order to investigate the mechanisms of connective tissue proteolysis by leukocytes, the
cellular source of the proteolytic activity was assessed by comparing intact cells with
lysed cells and cell supernatants. The proteolytic activity of viable C.parvum-elicited
bronchoalveolar leukocytes was greater than that of lysed cells or cell supernatants.
Supernatants of human peripheral blood neutrophils are also reported to be less active
than intact cells in causing breakdown of fibronectin in amnionic membranes (Sibille et al,
1986). There are several aspects of leukocyte function which could account for the greater
proteolytic activity of intact cells:- 1) loss of enzyme activity during production of
supernatants or lysates, 2) denovo synthesis of enzymes by alveolar macrophages in the
course of the assay, 3) acid proteinases such as cathepsin B (Chapman and Stone, 1984)
which is associated with the cell membrane, may play a part in matrix proteolysis by
intact cells and cell lysates but would not be active in cell supernatants, 4) viable cells may
have ways to maximise their ability to degrade connective tissue molecules; intact cells
may increase their proteolytic activity by localised sequestration of acid and/or neutral
proteinases at the site of close contact between the cell and the matrix (Werb et al, 1980;
Campbell et al, 1982). This could substantially increase their concentration at that point
and therefore increase their proteolytic potential, 5) proteinase inhibitors such as al-PI
and a2M, secreted by alveolar macrophages, may interact more readily with proteinase in
a cell-free system; the site of close contact between cells and matrix may exclude
concomitantly secreted inhibitors (Campbell et al, 1982) which would be free to inhibit
the proteinases in cell supernatants or lysates. However, inhibitor secretion by
macrophages is unlikely to have a major effect on the proteolytic activity of the
C.parvum-elicited leukocytes because macrophages comprise <15% of the leukocytes in
that population. Further experiments are therefore warranted to investigate the
mechanisms of increased matrix proteolysis by intact, viable leukocytes. A time course of
the proteolytic activity of leukocyte supernatants during 4hr incubation at 37°C would
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determine whether the proteinases lose activity during preparation of supernatants and
the contribution of membrane-bound proteinases to that activity could be estimated by
measuring proteolysis by isolated leukocyte membranes. The relative contribution of acid
and neutral proteinases to matrix proteolysis could be compared by measuring the
proteolytic activity of leukocyte supernatants at acid and neutral pH.
4.4. Inhibition profile of bronchoalveolar leukocytes
The lung parenchyma contains an antiproteinase screen which inactivates leukocyte
proteinases and thus prevents excessive tissue degradation under normal circumstances (see
1.4.4.). In chronic inflammatory lung disease the antiproteinase screen may be overcome by
the increased number and proteolytic activity of inflammatory leukocytes, so permitting
excessive connective tissue proteolysis and leading to tissue derangements (see 1.7.7.). The
inhibition profile of resident and inflammatory bronchoalveolar leukocyte populations in
response to al-PI and o2M, was therefore measured in order to assess their inhibitability
by antiproteinases present in the alveolar region. The proteolytic activity of both the
quartz and the C.parvum inflammatory leukocyte populations was significantly reduced
by each inhibitor but there was no significant reduction of control cell activity. The lack of
significant inhibition of the control cells probably reflects the low initial level of
proteolysis, which was barely above background. In other experiments where the
proteolytic activity of control leukocytes was greater, there was significant inhibition of
proteolysis but some residual proteolytic activity was always retained. Similarly,
although the proteolytic activity of the inflammatory bronchoalveolar leukocytes was
significantly reduced by the antiproteinases, a portion of their activity was also retained;
this suggests a possible mechanism whereby connective tissue damage may take place in
the lung, even in the presence of antiproteinases.
4.4.1. Exclusion of antiproteinases from sites of close contact between cells and
matrix
Large molecular weight inhibitors may be excluded from the site of close contact between
leukocytes and the extracellular matrix (Werb et al, 1980; Johnson and Varani, 1981;
Campbell et al, 1982; Chapman and Stone, 1984) and connective tissue proteolysis could
therefore proceed unimpeded at this privileged site. To test this hypothesis, control
leukocytes and inflammatory bronchoalveolar leukocytes elicited by TiC>2 or quartz
treatment were allowed to preadhere to a fibronectin matrix for 30 minutes before the
inhibitors were added to the wells. In wells where inhibitor and cells were added at the
same time, there was significant inhibition of the proteolysis caused by all three
leukocyte populations. However, no significant inhibition occurred in any of the wells
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where the cells had been preincubated on, and allowed to adhere to the matrix. This
indicates that inhibitors can indeed be excluded from the privileged site where cells and
extracellular matrix components are in intimate contact.
4.4.2. Ineffectiveness of the antiproteinase screen of the lung
The non-inhibitable portion of the proteolytic activity of resident alveolar macrophages
may contribute to the low-level turnover of connective tissue molecules in normal lungs
(Senior and Campbell, 1983; Gadek et al, 1984). In inflamed lung, both the total number
and proteolytic activity of leukocytes is greatly increased and gives rise to a consequently
increased proteinase burden in the alveolar region. Proteolytic injury in inflamed lung has
previously been thought to arise when the increased burden of secreted proteinases
overloads the antiproteinase screen. The results presented here suggest that the non-
inhibitable portion of leukocyte proteinase activity may also contribute to such injury.
4.43. Inhibition profile of leukocyte populations containing different
proportions of macrophages and neutrophils
The inhibition profile of the three leukocyte populations was not what would be predicted
from their neutrophil content. Macrophages secrete metalloproteinases (Banda and Werb,
1981; White et al, 1981b) and neutrophils secrete serine proteinases (Travis and Salvesen,
1983). Therefore, based on the experiments using exogenous proteinases, the C.parvum
(>80% neutrophils) and quartz (around 50% neutrophils) populations should have
responded differently to inhibition by the serine proteinase inhibitor, al-PI. In fact, they
were both equally inhibitable which suggested that the increased proteolytic activity of
both inflammatory populations was due to serine proteinases. This result might be
explained if the macrophages in the quartz population were in fact newly recruited
peripheral blood monocytes; these have been shown to contain serine proteinase activity
which is around 25% that of neutrophils (Senior and Campbell, 1983). In addition,
macrophages can sequester and subsequently release active neutrophil elastase (McGowan
et al,1984) and this may also contribute to the apparent serine proteinase activity of the
quartz leukocytes.
4.5. The proteolytic activity of human bronchoalveolar leukocyte
populations
4.5.1. Comparative activity of lung and peripheral blood leukocytes
Human leukocytes had proteolytic activity which varied depending on their source. Three
homogenous (ie >90% pure) populations of leukocytes were used:- 1) peripheral blood
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neutrophils, obtained from a healthy volunteer, 2) minced lung macrophages, prepared by
mincing excised human lung tissue, obtained from a site distal to a tumour and 3)
bronchoalveolar macrophages, obtained from the lungs of an ex-smoker suspected of having
a concurrent respiratory tract infection. The peripheral blood neutrophils, and minced lung
macrophages exhibited marked proteolytic activity which was dose and time dependent
but bronchoalveolar macrophages showed very little activity.
4.5.2. Factors influencing the proteolytic activity of bronchoalveolar leukocytes
Previous work investigating the proteolytic activity of human leukocytes has
demonstrated proteolytic activity in peripheral blood neutrophils which was increased in
patients with lung disease (Burnett et al, 1987). Interstitial leukocytes have been
previously shown to be functionally more active than alveolar leukocytes (Weissler et al,
1986) and this may account for some of the increased proteolytic activity of the minced lung
preparation. However, cytokines such as IL-1 and TNF are likely to be present throughout
tumour-bearing lungs and, through their actions in mediating leukocyte activation, may
also account for the increased proteolytic activity of the minced lung leukocytes (Larrick
and Kunkel, 1988). The low neutrophil count (1%) in the bronchoalveolar leukocyte
population suggested that the lungs were not acutely inflamed and therefore the leukocyte
population might be representative of resident alveolar macrophages. These results
suggest that in normal human lungs the resident alveolar macrophages have little
proteolytic activity. Bronchoalveolar macrophages from cigarette smokers (Hinman et al,
1980) and pneumoconiotics (Sablonniere et al, 1983), ie in situations where there is
inflammation and therefore inflammatory mediators in the lung, have increased
proteinase activity. This, and the finding of minimal proteolytic activity of the
bronchoalveolar leukocytes in the present study, supports the conclusions that 1) the
increased proteolytic activity of macrophages from the minced lung preparation was due to
activation by inflammatory mediators in vivo in the diseased lungs and 2) resident
bronchoalveolar macrophages have minimal proteolytic activity.
4.5.3. Effect of in vitro triggers on the proteolytic activity of human peripheral
blood and bronchoalveolar leukocytes
The proteolytic activity of the human peripheral blood neutrophils was increased
following triggering in vivo which may reflect their key role in acute inflammation and
host defence. The activity of the bronchoalveolar macrophages, however, was unaltered.
This may be indicative of the functional status of resident alveolar macrophages which is
suppressive of immune responses (Holt,1986) and may also render the macrophages
refractory to stimulation. However, alveolar macrophage responses to exogenous stimuli
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are complex and some require only a single stimulus, eg exposing bronchoalveolar
macrophages in xritro to quartz, causes increased production of IL-1 (Kusaka et al, in press).
Activation of alveolar macrophages for increased proteinase secretion may require the
synergistic action of several stimulatory factors such as IL-1, TNF and interferon gamma,
which occur at inflammatory sites (Billingham, 1987) and are likely to be present in the
milieu of inflamed lungs.
4.6. The relative contribution of inflammatory macrophages and
neutrophils to proteolytic injury in inflamed lungs
All of the foregoing results have demonstrated that in inflamed lung, there are substantial
increases in numbers of both macrophages and neutrophils. Many investigators propose
that neutrophils are the primary source of proteinase capable of damaging tissue in
inflamed lungs because of their large complement of proteinases (Spitznagel et al, 1980)
and since neutrophil elastase readily degrades elastin, collagen, fibronectin and
glycosaminoglycans (Senior and Campbell, 1983). Crystal et al (1984) regarded the
neutrophil as being so important to the disease process that they classified the interstitial
lung diseases as either neutrophilic or lymphocytic. However, macrophages are also
capable of substantial proteolytic activity (see 1.7.4.) and may therefore play an active
part in tissue proteolysis in inflamed lungs (Fels and Cohn, 1986). In chronic inflammatory
lung disease, neutrophils frequently comprise only 5 - 10% of the inflammatory leukocyte
population. So, even if their proteolytic potential is tenfold greater on a per cell basis than
that of macrophages, as previously suggested (Janoff et al, 1979; Gadek et al, 1984), their
proteolytic activity would not be greater than that of the remaining 90% of macrophages
in the alveolar region. In addition, neutrophil serine proteinases are more readily
inhibited than macrophage metalloproteinases by proteinase inhibitors such as al-PI in
the alveolar region. So macrophage proteinases may also play a key role in the
development of proteolytic damage in chronically inflamed lung.
4.6.1. Proteolytic activity of neutrophils and resident and inflammatory
macrophages from the bronchoalveolar region of the lung
To assess the relative proteolytic potential of inflammatory macrophages and
neutrophils, cells were separated from a quartz-elicited bronchoalveolar leukocyte
population that was approximately 50% macrophages and 50% neutrophils. The
proteolytic activity of a homogeneous population of inflammatory macrophages elicited
by intraperitoneal injection of tryptose phosphate broth was also assessed. All of the
inflammatory macrophage populations had increased proteolytic activity compared with
resident alveolar macrophages and exudate neutrophils had proteolytic activity which
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was around 15-30% greater than that of the inflammatory macrophages. Thus, compared
with resident alveolar macrophages, inflammatory lung macrophages do exhibit
increased proteolytic activity. In inflamed lungs where their numbers often substantially
outweigh those of neutrophils, macrophages may make a major contribution to proteolytic
damage. This finding may be of importance in the development of intervention strategies
for the prophylaxis and management of chronic inflammatory lung disease.
4.7. Comparative inflammogenic properties of particles deposited
in the lung by intratracheal instillation
4.7.1. Factors influencing the pathogenic potential of particles depositing in the
iung
Toxic products and growth factors are released by inflammatory leukocytes at sites of
inflammation in the lungs and so "bystander injury" to the surrounding host tissue, leading
to excessive tissue breakdown and/or mesenchymal overgrowth are likely to result. The
major difference between lung disease which resolves without causing pathological change
in the lung and pathogenic lung disease may be the magnitude and duration of the
alveolitis and the proteolytic activity of the bronchoalveolar leukocytes (Fantone and
Ward, 1984). In pneumoconiosis there are three key factors which could determine the
persistence of lung inflammation in response to mineral dust:- 1) duration of inhalation
exposure to particles, 2) deposition and retention of harmful particles within the alveolar
region and 3) persistence of the ability of particles in the lung to impart harm to the tissue.
The effects of duration of exposure to mineral dust in causing lung inflammation (Donaldson
et al, 1988a) and interstitial fibrosis (Davis et al, 1978) have been addressed previously
and these studies showed that both are dose- and time-related. The ability of particles to
persist within lung tissue has been assessed by measuring clearance rates following
inhalation exposure (Vincent and Donaldson, in press); that study showed little difference
in clearance between harmful and non-harmful dusts. Thus the major descriptor of the
intrinsic potential harmfulness of a dust appears to be the retention of its biological
reactivity in the lung.
4.7.2. The influence of type of particle on the magnitude and persistence of their
biological reactivity in the lung
The key parameters of the magnitude of the inflammogenic potential and persistence of
biological reactivity of particles deposited in rat lungs were assessed in the present study,
using particles of different durability and pathogenic potential. Comparisons were made
of the inflammatory response following a single intratracheal injection of the non-durable,
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biological particulates, C.parvum (a heat-killed bacterial preparation) and zymosan (an
extract of yeast cell walls), the inert dust, TiC>2 and the pathogenic dust, quartz; the latter
two are non-biodegradable particles. TiC>2 is a particulate that is widely used in the food
and paint industries but is not associated with pathology in occupationally exposed groups
(Chen and Fayerweather, 1988); it is commonly used as an "inert" control dust in
experimental studies in vitro (Le Bouffant et al, 1980; Donaldson and Brown, 1988) and in
vivo (Moores et al, 1980; Donaldson et al, 1988a). By contrast, occupational exposure to
quartz is associated with development of the fibrotic lung disease, silicosis (Davis, 1986)
and quartz has been shown to have potent cytotoxic effects in vitro (Donaldson and Brown,
1988) and marked inflammogenic potential (Donaldson et al, 1988a).
4.73. Assessment of the magnitude and persistence of biological reactivity of
different particles deposited in the lung
The results show that deposition of particulate matter in the lung evokes an inflammatory
response manifest as increases in the total number of lavageable leukocytes and the
proportion of neutrophils in the lavage population. This is true whether the particulate is
a typical biological inflammogen eg C.parvum or zymosan, a harmful mineral dust -
quartz, or an inert dust - Ti02- In contrast with the report by Shen et al (1988), the
pathogenic potential of particles was found to be independent of the magnitude of the
initial inflammatory response which they evoked. C.parvum, which does not cause
pathological change, following a single deposition in the lung caused the greatest
leukocyte recruitment at 1 day whilst quartz, which has marked pathological potential,
caused less leukocyte recruitment and was similar in activity to zymosan at that
timepoint. However, most strikingly, the persistence of the inflammatory response was
related to the pathogenic potential of the particles. Inflammation was rapidly resolved
with the two biological particles and TiC>2 but the pathogenic dust, quartz, evoked a
sustained alveolitis. The initial leukocyte recruitment is likely to be related to secretion of
leukocyte chemotaxins following phagocytosis of particles by the resident alveolar
macrophages (Lugano et al, 1982) and may also be related to direct complement activation
by interaction of particles with the alveolar lining fluid (Donaldson et al, 1987; Warheit
et al, 1988). The majority of particles depositing in the lung are no longer free to react
extracellularly after 1-2 days, due to phagocytosis (Ferin, 1971) or extracellular transport
to lymph nodes (Lehnert et al, 1988). The reduction in inflammation from 1 day onwards
supports the theory that phagocytosis and complement activation by free particles may be
an important mechanism in generating the acute inflammatory response. However,
alveolar inflammation in response to quartz did not subside after 1 day but increased up to
30 days after injection when there were ten-fold more leukocytes in the bronchoalveolar
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lavage of the quartz-exposed animals than in the controls, or in the other exposed groups.
So, alternative explanations must be sought for the sustained inflammogenic properties of
quartz.
4.7.4. Mechanisms of particle pathogenicity
A commonly invoked mechanism is that the pathogenic potential of a particle is related to
its cytotoxicity (Bowden and Adamson, 1984) but recent evidence suggests that other
mechanisms may also be involved in dust-induced inflammation in the lung. Quartz-
elicited bronchoalveolar leukocytes in this study and in rats exposed to quartz by
inhalation (Donaldson et al, 1988c) have been shown to be >99% viable and remained so
during 24h culture in vitro. Studies exposing control rat alveolar macrophages in vitro to low
levels of quartz also showed that the cells remained viable, although increasing the
concentration of quartz did lead to cell death ( Donaldson and Brown, 1988). The surface of
quartz particles is highly charged and reacts with cell membranes by acting as an electron
donor (Nolan et al, 1981). The charged surface of quartz may be the means whereby it kills
cells at high concentrations but at low concentrations, where the macrophages remain
viable, interaction of intracellular quartz with cell components may lead to macrophage
activation with its attendant consequences for enhancing and prolonging the inflammatory
response (Hamilton, 1980; Kusaka et al, in press). Further experiments have been carried
out to investigate the role of the free quartz surface in eliciting and sustaining an
inflammatory response and these are discussed in section 4.8.
4.7.5. Particle-elicited leukocyte proteinase burden in the alveolar space
Initially there were no differences in the proteolytic activity of leukocytes elicited by the
different particles. However, in keeping with the sustained nature of the quartz
alveolitis, the proteolytic activity of the quartz leukocytes also remained elevated; with
the other three particles, the proteolytic activity of the leukocytes decreased as the
alveolitis resolved. By integrating total leukocyte counts with proteolytic activity per
cell, a measure of the potential proteinase burden in the alveolar region was obtained for
each particulate. The difference between pathogenic and non-pathogenic particles was
immediately apparent. The overall alveolar proteinase burden was greatest in the
C.parvum-treated rats at 1 day but thereafter, only in the quartz-treated animals was
there a sustained elevated proteinase burden which was 5-fold greater than in the
controls. The lungs can therefore cope with a markedly elevated proteinase burden in an
acute situation (eg 1 day C.parvum) but where there is persistence of a lower level of
proteinase activity, then pathological change results. Thus the aspects of the biological
reactivity of quartz which appear to be related to its pathogenic potential are the ability
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to evoke and sustain alveolar inflammation and to thus maintain a persistent proteinase
burden in the alveolar region.
4.7.6. In vitro triggering of control and inflammatory leukocytes
It is of interest that despite the marked inflammogenic potential of the biological and
mineral dust particles following intratracheal injection, none had any effect in eliciting
leukocyte activation in vitro. Even the quartz particles, which do have some ability to
cause macrophage activation in vitro as assessed by IL-1 secretion (Kusaka et al, in press),
had no ability to elicit increased proteolytic activity in vitro. There is ample evidence
that leukocytes from other sites in the body eg the peritoneal cavity, secrete increased
levels of proteinases in response to a phagocytic stimulus (Werb and Reynolds, 1974). This
reinforces the theory that alveolar leukocytes are less readily stimulated and confirms
the previous work with human bronchoalveolar leukocytes (4.5.). The effect of quartz
particles on leukocytes may therefore be to prime them to respond to further signals in the
milieu of the inflamed lung. This question could be addressed by investigating the
proteolytic activity of leukocytes treated with quartz and inflammatory cytokines such as
IL-1 and TNF.
4.8. Inflammogenic effects of inhaled coalmine dust
4.8.1. Lung responses to coalmine dust in experimental models
There have been many studies which have investigated the in zntro biological effects of
coalmine dust (see 1.10.) but few which have assessed its in vivo effects. In the in xnvo
studies, the parameter most commonly studied has been the development of fibrotic lesions
in the lungs (Le Bouffant et al, 1977); only one previous report has measured the
inflammatory response to inhaled coalmine dust exposure (Bingham et al, 1977) and that
study considered the role of acid proteinases in the disease process. In the present study,
the role of neutral proteinases in the development of pneumoconiosis was addressed by
measuring the inflammatory response in lungs of rats inhaling coalmine dust; the
proteolytic activity of the bronchoalveolar leukocytes was then measured using the
fibronectin proteolysis assay. Chronic inhalation exposure for up to 52 days, to low levels
of coalmine dust, led to the gradual accumulation of inflammatory leukocytes in the
alveolar region. These results are contrary to those of Bingham et al (1977) who reported
no increase in total cells in the bronchoalveolar lavage of rats inhaling similar levels of
coalmine dust. However, fundamental differences in the method of preparing the dust may
explain these differences. The harmful minerals associated with the coalmining process
are derived, in the main, from the roof and floor of the coal seam and would form a very
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low part of the crushed coal sample used by Bingham et al (1977); crushed coal would also
produce a finer dust that would be less likely to deposit in the alveolar region.
4.8.2. Persistence of the inflammatory effect of coalmine dust, post-exposure
In the present study, the total number of leukocytes in the alveolar region was elevated
during dust exposure but returned to background levels during the 64 day post-exposure
period. However, the percentage of neutrophils remained elevated which suggests that
coalmine dust, like the quartz tested in the intratracheal study, has some ability to
sustain an inflammatory response. The persistent inflammatory response elicited by
coalmine dust, however, was less than that elicited by the more harmful dust, quartz. This
reinforces the suggestion that dusts which have pathogenic potential may act by eliciting
a sustained inflammatory response in the alveolar region and that response may be related
to the harmfulness of the dust.
4.83. Proteolytic burden in the alveolar region of rats inhaling coalmine dust
The proteolytic activity of the inflammatory leukocytes elicited by coalmine dust
inhalation was increased within 8 days of dust exposure. The increase was sustained for up
to 64 days post-exposure. The overall proteinase burden in the alveolar region is related to
both total leukocyte number and to the proteolytic activity of the inflammatory
leukocytes and is therefore greatly increased (6-fold increase compared with controls) in
the coalmine dust animals. Such an increase may lead to levels of proteinase in the
alveolar region that are sufficient to overload the antiproteinase screen and permit
connective tissue proteolysis to take place.
4.8.4. Inhibition profile of coalmine dust-elicited leukocytes
As previously described with other particles (4.4.), the inhibitor profile of the
inflammatory leukocytes elicited by coalmine dust suggested that the proteolytic activity
of inflammatory bronchoalveolar leukocytes was mediated by serine proteinases, the
serine proteinase inhibitor, al-PI was a more effective inhibitor of the leukocytes than
<x2M or the metalloproteinase inhibitor EDTA, even although the leukocyte population
was around 97% macrophages. It is unlikely that the 3% neutrophils in the population
could account for the increased proteolytic activity of the inflammatory leukocytes.
Monocytes secrete serine proteinases (Senior and Campbell, 1983) and thus newly-recruited
cells may make a contribution to the serine proteinase activity of the bronchoalveolar
leukocytes. However, monocytes change into morphologically typical alveolar
macrophages within a few hours of entering the alveolar space (Van oud Alblas et al,
1979) and so the actual levels of serine proteinase released by monocytes may be small.
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Further work with different specific inhibitors of serine and metalloproteinases is
therefore warranted to identify the type and cellular source of fibronectin-degrading
activity in the bronchoalveolar leukocytes.
4.8.5. In vitro triggering of the proteolytic activity of coalmine dust-elicited
bronchoalveolar leukocytes
In vitro treatment of inflammatory leukocytes with triggers eight days after the start of
dusting, again failed to elicit increased proteolytic activity (see 4.4. and 4.5) and may
reaffirm the unresponsiveness of alveolar leukocytes. However, in this part of the study
the proteolytic activity of the leukocytes increased eight days after the start of dust-
exposure but did not increase further thereafter. The proteolytic activity of the dust-
elicited leukocytes may therefore have been at maximum before the start of triggering.
4.8.6. Pathogenesis of pneumoconiosis
In the coalmining industry, continuous inhalation exposure to coalmine dust causes the
accumulation of elevated numbers of inflammatory leukocytes in the bronchoalveolar
region (Begin et al, 1986) and bronchoalveolar leukocytes from coalminers with
pneumoconiosis secrete increased levels of neutral proteinases (Hayem et al, 1980). Results
from the intratracheal exposure experiments in the present study (4.6.) link the ability to
sustain alveolar inflammation and to inflict a prolonged insult of inflammatory leukocyte-
derived proteinases on the lung tissue, with the potential to cause pathological change in
the lung. The finding of increased levels of leukocyte proteinases in the bronchoalveolar
lavage fluid of coalworkers with pneumoconiosis (Sablonniere et al, 1983) firmly
implicates such damage in the tissue derangements of fibrosis in coalworkers
pneumoconiosis (Ruckley et al, 1984) and may play a major part in the development of
emphysema in this disease.
4.8.7. Experimental results related to the progressive nature of pneumoconiosis
Persistence of bronchoalveolar inflammation, with increased proteolytic activity of the
inflammatory leukocytes, up to 64 days after cessation of dust exposure, suggests a possible
mechanism for the progression of pneumoconiosis in miners long after cessation of dust
exposure (Ruckley et al, 1984). It also lends support to one report that pulmonary
inflammation persists in retired coalmine workers as measured by clearance of Tc^m
DTPA (Susskind et al, 1989). These findings have implications for the long-term health of
persons who stop working in environments with high levels of coalmine dust but who may
have ongoing inflammation and increased proteinase levels in their lungs.
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4.9. Investigation of the pathogenicity of silica in relation to the
free quartz surface
4.9.1. Previous work on the surface modification of silica particles
The inflammogenic potential of silica has been related to its surface properties (Kreigseis
et al, 1987), which may be modified by compounds occurring in conjunction with quartz in
mixed dusts. Such compounds include iron, which reduces the fibrotic potential of silica
(Gross et al, 1960; Reichel et al, 1977) and aluminium which reduces both the
inflammogenicity and the fibrogenicity of silica (Begin et al, 1987a,b; Le Bouffant et al,
1977a). Aluminium is absorbed onto the surface of silica particles (Denny et al, 1939),
rendering it less refractive by electron diffraction, (Le Bouffant et al, 1977b), increasing its
zeta potential (Nolan et al, 1981) and increasing flocculation by reducing the solubility of
the particles (Denny et al, 1939). In addition, the quartz component of native silica dust
can be surface-modified by techniques that remove contaminants from the surface of the
quartz particles and render them more toxic to cells in vitro (Kreigseis et al, 1987). The
importance of the surface reactivity of quartz has also been demonstrated by showing that
freshly fractured quartz has greater biological activity - presumably because new,
uncontaminated surfaces are revealed (Heffernan, 1932; Fubini et al, 1987). Clay minerals
such as kaolin, mica, illite or smectite are potential sources of aluminium in mixed dusts
and a pilot study by Le Bouffant et al (1977b) has demonstrated reduced biological activity
of quartz when administered in conjunction with illite. Further experimental evidence in
vivo in support of the "antidotal rocks" theory of Bremner (1939) has demonstrated that
treatment with various aluminium or iron compounds in parallel with quartz-dosing
markedly reduced the pathogenicity of the quartz in rats (Gross et al, 1960; Le Bouffant et
al, 1977a), Guinea pigs (Gross et al, 1960), mice (King et al, 1953) and rabbits (Dworski,
1955). However, these studies reflected only the final outcome of the disease process by
measuring the extent of the pathological change in the lungs. In addition, assessment of
the protective effect of the aluminium and iron was complicated by the fact that they
were particulate in nature and could elicit an adverse reaction in the lung in their own
right (Shaver, 1948; Jordan, 1961; Reichel et al, 1977).
4.9.2. Inflammogenicity of aluminium lactate-coated quartz
More recently, experimental studies on the biological activity of quartz in vivo have used
soluble aluminium to modulate the effect of quartz in eliciting an inflammatory response
and subsequent pathological change in the lungs of sheep (Begin et al, 1987a). These
studies have shown that pre-treatment of quartz with soluble aluminium reduces the
113
inflammatory response as measured by bronchoalveolar lavage; tissue damage was also
markedly reduced.
In the present study, pretreatment of quartz with aluminium lactate reduced the total
number of leukocytes and percentage of neutrophils recruited to the alveolar region but did
not fully reduce the proteolytic activity of the leukocytes. These results are similar to
those found in the coal inhalation study where, 64 days post-exposure, the total leukocytes
returned to background levels but the percentage neutrophils and the proteolytic activity
of the population remained elevated; the overall potential proteinase burden in the
bronchoalveolar region (ie protease/cell x total cells in lavage) was 5-fold greater than
the controls. Similarly, in the animals dosed with quartz pre-treated with aluminium
lactate, total cells in lavage returned to background levels two months after the
intratracheal injection. However, although there was a decrease in both the percentage of
neutrophils in the population and in the proteolytic activity of the leukocytes, both of
these parameters remained greater than controls; the total potential proteinase burden in
the bronchoalveolar region in the quartz/aluminium lactate treated animals was 4-fold
that of the controls. This indicates that, although the harmful potential of the quartz
particles was attenuated by the aluminium treatment, it was not completely abolished.
This may be due to incomplete coating of the quartz particles or to other aspects of quartz
reactivity which are unaffected by the aluminium treatment.
4.93. Effect of delayed treatment with aluminium lactate on established quartz-
induced alveolitis
Late dosing with aluminium lactate one month into quartz exposure did not eliminate the
existing alveolitis and failed to reduce the proteolytic activity of the bronchoalveolar
leukocytes but did reduce the progression of the inflammatory response. This suggested
either that the aluminium lactate could gain access to the quartz particles in the lung or
that it was acting by suppressing the inflammatory leukocytes. The alveolitis evoked by
C.parvum was, however, unaffected by in vivo aluminium lactate treatment which
suggests that the effect of the aluminium lactate was due to some interaction with the
quartz particles and was not suppressive of the inflammatory leukocytes.
4.9.4. Histological examination of control, quartz and quartz/aluminium lactate
treated rat lungs
In paraffin section the tissue response agreed with the progressive nature of the
bronchoalveolar lavage results in quartz-exposed rats. Increasing tissue injury culminated
in marked alveolar lipoproteinosis and hyperplasia within the alveolar septa at three
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months. Reflecting the inflammatory response, the development of tissue changes in
response to quartz pre-treated with aluminium lactate was progressive but was markedly
attenuated compared with quartz alone. These results are in agreement with Begin et al
(1987a) who also demonstrated attenuated leukocyte responses and pathological change
with aluminium-coated quartz in sheep lungs. In the present study, late dosing with
aluminium lactate after the quartz response was established produced divergent responses
- the alveolitis was markedly reduced but there was no effect on the extent of tissue injury;
Begin et al (1987b) reported similar results in exposed sheep.
4.9.5. The biological activity of quartz in mixed dusts
The foregoing results strongly suggest that the free quartz surface is important in mediating
the pathogenic properties of quartz and that its biological activity is diminished in the
presence of aluminium. In mixed dusts, the pathogenic effect of quartz may be similarly
modulated by interaction with other minerals in the dust such as iron or aluminium silicate
clays. The interaction between quartz and aluminium can occur subsequent to a substantial
quartz-induced alveolitis but still significantly reduces the activity of the quartz. Thus, in
situations such as coalmining, where there can be significant temporal variation in the
mineralogical content of mixed dust, the pathogenic effect due to inhalation of a high
quartz content dust might be attenuated by subsequent inhalation of a dust containing
ameliorating minerals. These results may have a bearing on assessing the potential
harmfulness of any mixed dust but further research is required to understand the nature of
the interactions between quartz and other mineral components present in mixed dusts.
4.9.6. Prophylactic treatment with aluminium lactate
There have been many previous studies which have attempted to use aluminium therapy
as treatment in pneumoconiosis but the results have been inconclusive (Berry, 1948;
Kennedy, 1956; Dix, 1971). The present study suggests reasons for the variability of the
effectiveness of aluminium treatment by indicating that such treatment would reduce, but
not eliminate the harmful potential of inhaled quartz. Aluminium, however, exerts
harmful effects on the body in its own right (Sigel and Sigel, 1988). The use of aluminium
treatment in the prophylaxis of pneumoconiosis would only be warranted, therefore, in
cases of severe, acute silicosis which might otherwise be fatal within a short period of
time. While dust suppression must remain the rational goal in any strategy for reducing
pneumoconiosis, human error and ignorance will ensure that high exposure will still occur
and in these cases, any rational prophylaxis is worth considering at least.
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4.10. Summary
This work has investigated the mechanisms whereby connective tissue proteolysis may
lead to the fibrotic lesions of pneumoconiosis and the emphysema which often accompanies
them. The main findings of the study are as follows:-
I Particles deposited in the alveolar region of the lung evoke an inflammatory
response which is manifest as increases in the total number and percentage of
neutrophils in the bronchoalveolar lavage.
II Inflammatory bronchoalveolar macrophages and neutrophils have increased
proteolytic activity compared with resident alveolar macrophages and together
with the increased number of leukocytes, this leads to a markedly increased
proteolytic burden in inflamed lungs.
III Measuring the proteolytic activity of intact leukocytes gives a better indication of
their overall ability to damage the extracellular matrix of the alveolar septa than
can be obtained by measuring a single secreted enzyme such as elastase.
IV The magnitude of the initial inflammogenic response to particles deposited by
intratracheal instillation is not related to their pathogenic potential but the
duration of the alveolitis appears to be a major descriptor of their potential
harmfulness.
V The ability of particles to evoke and sustain an inflammatory response is not solely
reliant on particle durability.
VI The magnitude of the persistent alveolitis in response to quartz and coalmine dust in
the lung, in common with the increased proteolytic activity of the bronchoalveolar
leukocytes, reflects the pathogenic potential of the two dusts and may be associated
with disease progression.
VII The inflammogenic properties of quartz are related to its surface reactivity in
biological systems. The ability of aluminium to modify the surface of the quartz
particles, so rendering them less harmful, suggests that this may occur in mixed dusts
containing aluminium silicate clays. Coating of the quartz particles may account for
the low prevalence of pneumoconiosis in some collieries where there is a high quartz
content in the coalmine dust.
VIII Bronchoalveolar leukocytes are less readily activated than peripheral blood
neutrophils in vitro. This may be a reflection of the unique situation of the
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bronchoalveolar leukocytes in that they are constantly exposed to exogenous
material. Inflammatory responses which would be appropriate elsewhere in the
body, in the lungs could quickly lead to life-threatening alveolitis and tissue
destruction and are therefore suppressed.
IX A portion of the proteolytic activity of both resident and inflammatory leukocytes is
non-inhibitable. In healthy lungs, this may be associated with normal tissue
turnover but in inflamed lungs it may be the means whereby proteolytic damage
occurs despite the presence of the antiproteinase screen.
X The proteinase burden in inflamed lungs may be derived from either, or both the
macrophages and neutrophils which constitute the alveolitis.
This study has investigated the mechanisms whereby inhalation of mineral dusts such as
coalmine dust and quartz can lead to the development of pneumoconiosis. The influence of
type of particle, duration of exposure, retention of biological reactivity of the particles
and how that reactivity can be modified have been considered. The relationship between
the alveolitis and the disease process has been addressed by assessing the potential role
and the type of leukocyte proteinases involved in the disease process. The outcome of the
study is to provide some insight into the way that disease develops in relation to dust
exposure. The results may be of use in developing treatment for men who have already been
exposed to harmful levels of dust but may also help in developing effective control
strategies in order to prevent such exposures in the future.
4.11. Further work arising from the study
1 Knowledge of the role of macrophage and neutrophil proteinases could be of
importance in the development of inhibitors of leukocyte proteinases for use in the
alveolar region. A considerable amount of research effort has been expended in
developing inhibitors of neutrophil elastase but there has been little work done in
the field of macrophage proteinases. An investigation of the type and
inhibitability of inflammatory macrophage proteinase would be useful following
the demonstration in this study that inflammatory macrophages have considerable
proteolytic activity and may play a part in tissue damage in chronic inflammatory
lung disease. Such a study could be accomplished, initially, by further use of specific
proteinase inhibitors in the fibronectin proteolysis assay.
2 Inflammatory mediators are likely to be present in the milieu of dust-inflamed lungs
and may account for the increased proteolytic activity of the lavaged leukocytes.
The non-responsiveness of resident alveolar macrophages to dust exposure in vitro
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makes them an ideal model for investigating the role of cytokines such as IL-1, TNF
and gamma-interferon in increasing the proteolytic activity of macrophages in dust-
exposed lungs. The question could be addressed by treating control macrophages in
vitro with a variety of particles of known pathogenic potential and measuring their
proteolytic activity as above. Recombinant cytokines could then be added into the
assay, either alone or in combination to assess the effects of synergy.
3 The in vivo exposure model would lend itself to assessing the effect of drugs in
modulating the inflammatory response in the bronchoalveolar region.
4 All of the experiments in the present study have been carried out using a single dose
of particles. Further work to establish dose-response curves for the particles,
particularly quartz, should be carried out.
5 Estimation of the persistent inflammogenic potential of coalmine-dust was carried
out over a very short time. It would be very interesting to extend the time period to
determine whether the inflammation would resolve. Results not presented in this
thesis, have indicated that the alveolitis in response to a single intratracheal dose
of lmg of quartz, persists for at least one year. The magnitude and duration of the
alveolitis in response to smaller amounts of quartz are also of interest.
6 The leukocyte populations tested in this study were obtained from the
bronchoalveolar space as a first step in understanding the mechanisms of the
pathogenesis of chronic inflammatory lung disease in general and pneumoconiosis in
particular. The next phase of the work should encompass a study of the interstitial
leukocytes. These are the cells that are in the most intimate contact with the fixed
cells and connective tissue of the alveolar septa and may therefore be more
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